{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:09:35Z","timestamp":1791648575629,"version":"4.3.4"},"reference-count":571,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T00:00:00Z","timestamp":1607299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2014S GR 541"],"award-info":[{"award-number":["2014S GR 541"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/00377"],"award-info":[{"award-number":["PI16\/00377"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>As aerobic organisms, we are continuously and throughout our lifetime subjected to an oxidizing atmosphere and, most often, to environmental threats. The lung is the internal organ most highly exposed to this milieu. Therefore, it has evolved to confront both oxidative stress induced by reactive oxygen species (ROS) and a variety of pollutants, pathogens, and allergens that promote inflammation and can harm the airways to different degrees. Indeed, an excess of ROS, generated intrinsically or from external sources, can imprint direct damage to key structural cell components (nucleic acids, sugars, lipids, and proteins) and indirectly perturb ROS-mediated signaling in lung epithelia, impairing its homeostasis. These early events complemented with efficient recognition of pathogen- or damage-associated recognition patterns by the airway resident cells alert the immune system, which mounts an inflammatory response to remove the hazards, including collateral dead cells and cellular debris, in an attempt to return to homeostatic conditions. Thus, any major or chronic dysregulation of the redox balance, the air\u2013liquid interface, or defects in epithelial proteins impairing mucociliary clearance or other defense systems may lead to airway damage. Here, we review our understanding of the key role of oxidative stress and inflammation in respiratory pathology, and extensively report current and future trends in antioxidant and anti-inflammatory treatments focusing on the following major acute and chronic lung diseases: acute lung injury\/respiratory distress syndrome, asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and cystic fibrosis.<\/jats:p>","DOI":"10.3390\/ijms21239317","type":"journal-article","created":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T12:24:39Z","timestamp":1607343879000},"page":"9317","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Airway Redox Homeostasis and Inflammation Gone Awry: From Molecular Pathogenesis to Emerging Therapeutics in Respiratory Pathology"],"prefix":"10.3390","volume":"21","author":[{"given":"Javier","family":"Checa","sequence":"first","affiliation":[{"name":"Immune-Inflammatory Processes and Gene Therapeutics Group, IDIBELL, L\u2019Hospitalet de Llobregat, 08908 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2827-9392","authenticated-orcid":false,"given":"Josep M.","family":"Aran","sequence":"additional","affiliation":[{"name":"Immune-Inflammatory Processes and Gene Therapeutics Group, IDIBELL, L\u2019Hospitalet de Llobregat, 08908 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,7]]},"reference":[{"key":"ref_1","first-page":"1","article-title":"Inflammatory mechanisms in the lung","volume":"2","author":"Moldoveanu","year":"2009","journal-title":"J. Inflamm. Res."},{"key":"ref_2","first-page":"15","article-title":"Mecanismos de defensa pulmonar","volume":"6","author":"Sibilia","year":"2013","journal-title":"Med. Respir."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fimmu.2020.00003","article-title":"Respiratory Barrier as a Safeguard and Regulator of Defense Against Influenza A Virus and Streptococcus pneumoniae","volume":"11","author":"LeMessurier","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e24997","DOI":"10.4161\/tisb.24997","article-title":"Barrier function of airway tract epithelium","volume":"1","author":"Ganesan","year":"2013","journal-title":"Tissue Barriers"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e1367458","DOI":"10.1080\/21688370.2017.1367458","article-title":"Airway epithelial barrier dysfunction in the pathogenesis and prognosis of respiratory tract diseases in childhood and adulthood","volume":"5","author":"Yuksel","year":"2017","journal-title":"Tissue Barriers"},{"key":"ref_6","first-page":"477","article-title":"Cough, a vital reflex. Mechanisms, determinants and measurements","volume":"89","author":"Andrani","year":"2018","journal-title":"Acta Biomed."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"20190160","DOI":"10.1098\/rstb.2019.0160","article-title":"Multiscale mechanics of mucociliary clearance in the lung","volume":"375","author":"Nawroth","year":"2020","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1513\/pats.200508-089JS","article-title":"Humoral immune defense (antibodies): Recent advances","volume":"2","author":"Twigg","year":"2005","journal-title":"Proc. Am. Thorac. Soc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1080\/21505594.2018.1526531","article-title":"Innate humoral immune defences in mammals and insects: The same, with differences?","volume":"9","author":"Sheehan","year":"2018","journal-title":"Virulence"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1159\/000487057","article-title":"Innate Immunity of the Lung: From Basic Mechanisms to Translational Medicine","volume":"10","author":"Hartl","year":"2018","journal-title":"J. Innate Immun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1183\/09031936.00141514","article-title":"The innate immune function of airway epithelial cells in inflammatory lung disease","volume":"45","author":"Hiemstra","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00441-017-2748-z","article-title":"Neutrophils in the lung: \u201cThe first responders\u201d","volume":"371","author":"Aulakh","year":"2018","journal-title":"Cell Tissue Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"9095275","DOI":"10.1155\/2018\/9095275","article-title":"Eosinophils from Physiology to Disease: A Comprehensive Review","volume":"2018","author":"Ramirez","year":"2018","journal-title":"BioMed Res. Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/MOT.0000000000000313","article-title":"Role of monocytes and macrophages in regulating immune response following lung transplantation","volume":"21","author":"Chiu","year":"2016","journal-title":"Curr. Opin. Organ Transplant."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1136\/thoraxjnl-2015-207020","article-title":"Pulmonary macrophages: Key players in the innate defence of the airways","volume":"70","author":"Byrne","year":"2015","journal-title":"Thorax"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3389\/fimmu.2019.01416","article-title":"Natural killer cells in the lungs","volume":"10","author":"Cong","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1183\/09059180.00005014","article-title":"Mast cells in human airways: The culprit?","volume":"23","year":"2014","journal-title":"Eur. Respir. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/1753425918821732","article-title":"Regulation of lung immunity by dendritic cells: Implications for asthma, chronic obstructive pulmonary disease and infectious disease","volume":"25","author":"Peters","year":"2019","journal-title":"Innate Immun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1165\/rcmb.2014-0334OC","article-title":"The induction of pattern-recognition receptor expression against influenza a virus through Duox2-derived reactive oxygen species in nasal mucosa","volume":"53","author":"Kim","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Tengroth, L., Millrud, C.R., Kvarnhammar, A.M., Geor\u00e9n, S.K., Latif, L., and Cardell, L.O. (2014). Functional effects of Toll-Like Receptor (TLR)3, 7, 9, RIG-I and MDA-5 stimulation in nasal epithelial cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0098239"},{"key":"ref_21","first-page":"1","article-title":"Toll-like receptors activation, signaling, and targeting: An overview","volume":"43","author":"Sibaii","year":"2019","journal-title":"Bull. Natl. Res. Cent."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.it.2013.06.003","article-title":"Toll-like receptor regulation of effector T lymphocyte function","volume":"34","author":"Reynolds","year":"2013","journal-title":"Trends Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s12016-017-8609-4","article-title":"Intracellular B Lymphocyte Signalling and the Regulation of Humoral Immunity and Autoimmunity","volume":"53","author":"Taher","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Gomes, E.C., and Florida-James, G. (2014). Lung Inflammation, Oxidative Stress and Air Pollution. Lung Inflammation, IntechOpen.","DOI":"10.5772\/58252"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"487074","DOI":"10.1155\/2011\/487074","article-title":"Oxidative Stress and Air Pollution Exposure","volume":"2011","author":"Lodovici","year":"2011","journal-title":"J. Toxicol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Ozcan, A., and Ogun, M. (2015). Biochemistry of Reactive Oxygen and Nitrogen Species. Basic Principles and Clinical Significance of Oxidative Stress, IntechOpen.","DOI":"10.5772\/61193"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-4614-3573-0_6","article-title":"Molecular mechanisms of superoxide production by the mitochondrial respiratory chain","volume":"748","author":"Brandt","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-94-007-2869-1_5","article-title":"Mitochondria and reactive oxygen species. Which role in physiology and pathology?","volume":"942","author":"Lenaz","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_29","first-page":"1364","article-title":"ROS generation in peroxisomes and its role in cell signaling","volume":"57","year":"2016","journal-title":"Plant Cell Physiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10059-011-0276-3","article-title":"Do Regulation of reactive oxygen species generation in cell signaling","volume":"32","author":"Bae","year":"2011","journal-title":"Mol. Cells"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1152\/physrev.00036.2017","article-title":"Sources of vascular nitric oxide and reactive oxygen species and their regulation","volume":"99","author":"Tejero","year":"2019","journal-title":"Physiol. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3103\/S009639251804003X","article-title":"Role of Reactive Oxygen Species in Inflammation: A Minireview","volume":"73","author":"Chelombitko","year":"2018","journal-title":"Mosc. Univ. Biol. Sci. Bull."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.freeradbiomed.2012.04.022","article-title":"Regulation of innate immunity by NADPH oxidase","volume":"53","author":"Segal","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive oxygen species in inflammation and tissue injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/bph.14158","article-title":"Dual oxidase: A novel therapeutic target in allergic disease","volume":"175","author":"Danyal","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Yang, H.T., Huang, Y.H., and Yang, G.W. (2019). Mini review: Immunologic functions of dual oxidases in mucosal systems of vertebrates. Braz. J. Biol.","DOI":"10.1590\/1519-6984.208749"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1089\/ars.2009.2558","article-title":"Mechanisms and function of DUOX in epithelia of the lung","volume":"11","author":"Fischer","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"101268","DOI":"10.1016\/j.redox.2019.101268","article-title":"The dynamic uptake and release of SOD3 from intracellular stores in macrophages modulates the inflammatory response","volume":"26","author":"Hu","year":"2019","journal-title":"Redox Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1164\/rccm.200212-1479SO","article-title":"Superoxide dismutases in the lung and human lung diseases","volume":"167","author":"Kinnula","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1152\/physiolgenomics.90363.2008","article-title":"Superoxide dismutase 3, extracellular (SOD3) variants and lung function","volume":"37","author":"Ganguly","year":"2009","journal-title":"Physiol. Genom."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.biopha.2005.03.010","article-title":"Extracellular superoxide dismutase: Structural and functional considerations of a protein shaped by two different disulfide bridge patterns","volume":"59","author":"Petersen","year":"2005","journal-title":"Biomed. Pharmacother."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejphar.2005.12.087","article-title":"Oxidant and antioxidant balance in the airways and airway diseases","volume":"533","author":"Rahman","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.4049\/jimmunol.1900820","article-title":"Enhanced Expression of Catalase in Mitochondria Modulates NF-\u03baB\u2013Dependent Lung Inflammation through Alteration of Metabolic Activity in Macrophages","volume":"205","author":"Han","year":"2020","journal-title":"J. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1165\/rcmb.2011-0345OC","article-title":"Glutathione peroxidase-1 reduces influenza A virus-induced lung inflammation","volume":"48","author":"Yatmaz","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1089\/ars.2019.7752","article-title":"Peroxiredoxins and Beyond; Redox Systems Regulating Lung Physiology and Disease","volume":"31","author":"Elko","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/978-1-4020-6051-9_15","article-title":"Peroxiredoxins in the lung with emphasis on peroxiredoxin VI","volume":"44","author":"Schremmer","year":"2007","journal-title":"Subcell. Biochem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/thorax.57.2.157","article-title":"Cell specific expression of peroxiredoxins in human lung and pulmonary sarcoidosis","volume":"57","author":"Kinnula","year":"2002","journal-title":"Thorax"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1440-1843.2006.00849.x","article-title":"Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung","volume":"11","author":"Park","year":"2006","journal-title":"Respirology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.pupt.2012.01.002","article-title":"Role of thioredoxin in lung disease","volume":"25","author":"Xu","year":"2012","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"65","DOI":"10.14348\/molcells.2016.2349","article-title":"The Roles of peroxiredoxin and thioredoxin in hydrogen peroxide sensing and in signal transduction","volume":"39","author":"Netto","year":"2016","journal-title":"Mol. Cells"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1089\/ars.2005.7.60","article-title":"Redox regulation of lung inflammation by thioredoxin","volume":"7","author":"Nakamura","year":"2005","journal-title":"Antioxid. Redox Signal."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/08923973.2020.1755309","article-title":"The expression of thioredoxin-1 and inflammatory cytokines in patients with sepsis","volume":"42","author":"Shao","year":"2020","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.freeradbiomed.2017.10.350","article-title":"Glutathione, Glutaredoxin And S-Glutathionylation In Lung Disease","volume":"112","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"C304","DOI":"10.1152\/ajpcell.00410.2019","article-title":"Dysregulation of the glutaredoxin\/S-glutathionylation redox axis in lung diseases","volume":"318","author":"Chia","year":"2020","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/014107680710001109","article-title":"Vitamin C may affect lung infections","volume":"100","author":"Louhiala","year":"2007","journal-title":"J. R. Soc. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/thoraxjnl-2014-205751","article-title":"Antioxidants and respiratory disease: The uric acid paradox","volume":"69","author":"Shaheen","year":"2014","journal-title":"Thorax"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/ars.2011.4198","article-title":"Glutathione redox control of asthma: From molecular mechanisms to therapeutic opportunities","volume":"17","author":"Fitzpatrick","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1465-9921-12-133","article-title":"Lung glutathione adaptive responses to cigarette smoke exposure","volume":"12","author":"Gould","year":"2011","journal-title":"Respir. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/iub.2008","article-title":"Vitamin E: Regulatory Redox Interactions","volume":"71","author":"Miyazawa","year":"2019","journal-title":"IUBMB Life"},{"key":"ref_60","first-page":"185","article-title":"Oxidants, antioxidants, and respiratory tract lining fluids","volume":"102","author":"Cross","year":"1994","journal-title":"Environ. Health Perspect."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1080\/08958370802603789","article-title":"Antioxidant responses to acute ozone challenge in the healthy human airway","volume":"21","author":"Behndig","year":"2009","journal-title":"Inhal. Toxicol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1183\/09031936.99.13614399","article-title":"Antioxidant consumption and repletion kinetics in nasal lavage fluid following exposure of healthy human volunteers to ozone","volume":"13","author":"Mudway","year":"1999","journal-title":"Eur. Respir. J."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Barthelemy, J., Sanchez, K., Miller, M.R., and Khreis, H. (2020). New opportunities to mitigate the burden of disease caused by traffic related air pollution: Antioxidant-rich diets and supplements. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17020630"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.freeradbiomed.2004.11.009","article-title":"Antioxidant-mediated augmentation of ozone-induced membrane oxidation","volume":"38","author":"Ballinger","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1089\/ars.2006.8.76","article-title":"Nrf2 defends the lung from oxidative stress","volume":"8","author":"Cho","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.3389\/fimmu.2018.01896","article-title":"The Nrf2-antioxidant response element signaling pathway controls fibrosis and autoimmunity in scleroderma","volume":"9","author":"Kavian","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1021\/tx300145n","article-title":"Nrf2: Friend and Foe in preventing cigarette smoking-dependent lung disease","volume":"25","author":"Hengstermann","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mrrev.2007.11.006","article-title":"Nrf2 signaling: An adaptive response pathway for protection against environmental toxic insults","volume":"659","author":"Osburn","year":"2008","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00011-018-1191-2","article-title":"A review of inflammatory mechanism in airway diseases","volume":"68","author":"Aghasafari","year":"2019","journal-title":"Inflamm. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1440-1843.2008.01447.x","article-title":"Impact of oxidative stress on lung diseases","volume":"14","author":"Park","year":"2009","journal-title":"Respirology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-019-0069-0","article-title":"Acute respiratory distress syndrome","volume":"5","author":"Matthay","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_72","first-page":"1","article-title":"Hypoxemic Respiratory Failure from Acute Respiratory Distress Syndrome Secondary to Leptospirosis","volume":"2017","author":"Fernando","year":"2017","journal-title":"Case Rep. Crit. Care"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(67)90168-7","article-title":"Acute respiratory distress in adults","volume":"2","author":"Ashbaugh","year":"1967","journal-title":"Lancet"},{"key":"ref_74","first-page":"2526","article-title":"Acute respiratory distress syndrome: The Berlin definition","volume":"307","author":"Ranieri","year":"2012","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1513\/AnnalsATS.201609-728PS","article-title":"Acute respiratory distress syndrome and diffuse alveolar damage new insights on a complex relationship","volume":"14","author":"Lorente","year":"2017","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4187\/respcare.04644","article-title":"What\u2019s next after ARDS: Long-term outcomes","volume":"61","author":"Chiumello","year":"2016","journal-title":"Respir. Care"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1513\/AnnalsATS.201407-340MG","article-title":"Mechanisms and clinical consequences of acute lung injury","volume":"12","author":"Fanelli","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-3-319-63245-2_8","article-title":"ROS signaling in the pathogenesis of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS)","volume":"Volume 967","author":"Kellner","year":"2017","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/thoraxjnl-2016-209170","article-title":"What drives neutrophils to the alveoli in ARDS?","volume":"72","author":"Zemans","year":"2017","journal-title":"Thorax"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/path.5221","article-title":"Neutrophils in the initiation and resolution of acute pulmonary inflammation: Understanding biological function and therapeutic potential","volume":"247","author":"Potey","year":"2019","journal-title":"J. Pathol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/CCM.0b013e31819261db","article-title":"Fio2 and acute respiratory distress syndrome definition during lung protective ventilation","volume":"37","author":"Forel","year":"2009","journal-title":"Crit. Care Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1164\/rccm.201606-1306OC","article-title":"Noninvasive Ventilation of Patients with Acute Respiratory Distress Syndrome: Insights from the LUNG SAFE Study","volume":"195","author":"Bellani","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.rcl.2016.05.006","article-title":"Imaging of Acute Lung Injury","volume":"54","author":"Elicker","year":"2016","journal-title":"Radiol. Clin. N. Am."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s00134-016-4328-1","article-title":"Imaging in acute respiratory distress syndrome","volume":"42","author":"Pesenti","year":"2016","journal-title":"Intensive Care Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.nucmedbio.2017.01.005","article-title":"18F-fluoro-2-deoxyglucose PET informs neutrophil accumulation and activation in lipopolysaccharide-induced acute lung injury","volume":"48","author":"Rodrigues","year":"2017","journal-title":"Nucl. Med. Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"5843672","DOI":"10.1155\/2016\/5843672","article-title":"Morin attenuates ovalbumin-induced airway inflammation by modulating oxidative stress-responsive MAPK signaling","volume":"2016","author":"Ma","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Lee, K.Y. (2017). Pneumonia, acute respiratory distress syndrome, and early immune-modulator therapy. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18020388"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.29390\/cjrt-2018-016","article-title":"Fluid management in Acute Respiratory Distress Syndrome: A narrative review","volume":"50","author":"Keddissi","year":"2019","journal-title":"Can. J. Respir. Ther."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13223-018-0279-0","article-title":"Asthma","volume":"14","author":"Quirt","year":"2018","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/alr.21609","article-title":"Asthma: Definitions and pathophysiology","volume":"5","author":"Mims","year":"2015","journal-title":"Int. Forum Allergy Rhinol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fped.2019.00068","article-title":"Pathophysiological mechanisms of asthma","volume":"7","author":"Bush","year":"2019","journal-title":"Front. Pediatr."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nri3786","article-title":"Type 2 inflammation in asthma-present in most, absent in many","volume":"15","author":"Fahy","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0167-5699(00)01634-0","article-title":"CCL chemokines and asthma","volume":"21","author":"Teran","year":"2000","journal-title":"Immunol. Today"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.jaci.2014.09.006","article-title":"Prostaglandin D2 and leukotriene E4 synergize to stimulate diverse TH2 functions and TH2 cell\/neutrophil crosstalk","volume":"135","author":"Xue","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3109\/02770903.2014.917659","article-title":"CCL11 as a potential diagnostic marker for asthma?","volume":"51","author":"Wu","year":"2014","journal-title":"J. Asthma"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fmed.2017.00093","article-title":"The biology of eosinophils and their role in asthma","volume":"4","author":"McBrien","year":"2017","journal-title":"Front. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1067\/mai.2002.126780","article-title":"Oxidative stress in allergic respiratory diseases","volume":"110","author":"Bowler","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pharmthera.2017.08.011","article-title":"Oxidative stress and cellular pathways of asthma and inflammation: Therapeutic strategies and pharmacological targets","volume":"181","author":"Mishra","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1053\/rmed.1999.0801","article-title":"Inhaled glucocorticosteroids decrease hydrogen peroxide level in expired air condensate in asthmatic patients","volume":"94","author":"Antczak","year":"2000","journal-title":"Respir. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/WOX.0b013e318232389e","article-title":"Oxidative stress in asthma","volume":"4","author":"Sahiner","year":"2011","journal-title":"World Allergy Organ. J."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ccm.2008.03.014","article-title":"The Immunology of Sarcoidosis","volume":"29","author":"Gerke","year":"2008","journal-title":"Clin. Chest Med."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Lan, N., Luo, G., Yang, X., Cheng, Y., Zhang, Y., Wang, X., Wang, X., Xie, T., Li, G., and Liu, Z. (2014). 25-hydroxyvitamin D3-deficiency enhances oxidative stress and corticosteroid resistance in severe asthma exacerbation. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0111599"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1136\/thorax.55.suppl_2.S51","article-title":"Oxidant stress in asthma","volume":"55","author":"Dworski","year":"2000","journal-title":"Thorax"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Arora, P., and Ansari, S.H. (2019). Role of Various Mediators in Inflammation of Asthmatic Airways. Asthma\u2014Biological Evidences, IntechOpen.","DOI":"10.5772\/intechopen.84357"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.21037\/jtd.2017.01.05","article-title":"Recent developments in the role of reactive oxygen species in allergic asthma","volume":"9","author":"Qu","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1006\/pupt.2001.0319","article-title":"Reactive oxygen species as mediators in asthma","volume":"14","author":"Henricks","year":"2001","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.immuni.2019.03.018","article-title":"The Cytokines of Asthma","volume":"50","author":"Lambrecht","year":"2019","journal-title":"Immunity"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"113690","DOI":"10.1016\/j.bcp.2019.113690","article-title":"The \u03b22-adrenergic receptor-ROS signaling axis: An overlooked component of \u03b22AR function?","volume":"171","author":"Rambacher","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Llano-Diez, M., Sinclair, J., Yamada, T., Zong, M., Fauconnier, J., Zhang, S.J., Katz, A., Jardemark, K., Westerblad, H., and Andersson, D.C. (2016). The role of reactive oxygen species in \u03b2-adrenergic signaling in cardiomyocytes from mice with the metabolic syndrome. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0167090"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3892\/br.2015.502","article-title":"Suppression of the increasing level of acetylcholine-stimulated intracellular Ca2+ in guinea pig airway smooth muscle cells by mabuterol","volume":"3","author":"Song","year":"2015","journal-title":"Biomed. Rep."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Tang, W. (2019). Role of Airway Smooth Muscle Cells in Asthma Pathology. Asthma\u2014Biological Evidences, IntechOpen.","DOI":"10.5772\/intechopen.84363"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fped.2017.00162","article-title":"Oxidative stress and bronchial asthma in children-causes or consequences?","volume":"5","author":"Jesenak","year":"2017","journal-title":"Front. Pediatr."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4168\/aair.2010.2.3.183","article-title":"The role of oxidative stress in the pathogenesis of asthma","volume":"2","author":"Cho","year":"2010","journal-title":"Allergy Asthma Immunol. Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"7210","DOI":"10.2741\/3223","article-title":"Oxidative stress-induced disruption of epithelial and endothelial tight junctions","volume":"13","author":"Rao","year":"2008","journal-title":"Front. Biosci."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3389\/fphys.2020.00472","article-title":"Oxidative Stress and Microvessel Barrier Dysfunction","volume":"11","author":"He","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.chest.2016.01.024","article-title":"NADPH Oxidase-4 Overexpression Is Associated with Epithelial Ciliary Dysfunction in Neutrophilic Asthma","volume":"149","author":"Wan","year":"2016","journal-title":"Chest"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1128\/JVI.02685-06","article-title":"Sensing Infection by Adenovirus: Toll-Like Receptor-Independent Viral DNA Recognition Signals Activation of the Interferon Regulatory Factor 3 Master Regulator","volume":"81","author":"Nociari","year":"2007","journal-title":"J. Virol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1074\/jbc.M410592200","article-title":"Involvement of Toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus","volume":"280","author":"Guillot","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1126\/science.1093616","article-title":"Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA","volume":"303","author":"Diebold","year":"2004","journal-title":"Science"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/80833","article-title":"Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus","volume":"1","author":"Popova","year":"2000","journal-title":"Nat. Immunol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1042\/BST0351151","article-title":"Redox regulation of lung inflammation: Role of NADPH oxidase and NF-\u03baB signalling","volume":"35","author":"Yao","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0952-7915(03)00067-0","article-title":"Cell-mediated immunity to respiratory virus infections","volume":"15","author":"Woodland","year":"2003","journal-title":"Curr. Opin. Immunol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"61","DOI":"10.29262\/ram.v65i1.306","article-title":"Vitaminas antioxidantes en asma","volume":"65","year":"2018","journal-title":"Rev. Alerg. M\u00e9xico"},{"key":"ref_124","unstructured":"Comhair, S., Khan, A., and Erzurum, S. (2011). Superoxide dismutase as a longitudinal biomarker of lung function in asthma. Eur. Respir. J., 38."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0002-9440(10)62286-9","article-title":"SOD inactivation in asthma: Bad news or NO news?","volume":"166","author":"Ckless","year":"2005","journal-title":"Am. J. Pathol."},{"key":"ref_126","first-page":"72","article-title":"The use of superoxide dismutase in accelerating symptom relief in asthmatic and house dust mite allergic children receiving house dust mite immunotherapy: Double blind randomized controlled clinical trial","volume":"3","author":"Endaryanto","year":"2015","journal-title":"Int. J. Integr. Health Sci."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1089\/ars.2012.4566","article-title":"Disulfide bond as a switch for copper-zinc superoxide dismutase activity in asthma","volume":"18","author":"Ghosh","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1172\/JCI11963","article-title":"TGF-\u03b2 is a critical mediator of acute lung injury","volume":"107","author":"Pittet","year":"2001","journal-title":"J. Clin. Investig."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0002-9440(10)62288-2","article-title":"Superoxide dismutase inactivation in pathophysiology of asthmatic airway remodeling and reactivity","volume":"166","author":"Comhair","year":"2005","journal-title":"Am. J. Pathol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/ars.2008.2425","article-title":"Redox control of asthma: Molecular mechanisms and therapeutic opportunities","volume":"12","author":"Comhair","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.4049\/jimmunol.176.9.5587","article-title":"Nitrotyrosine Proteome Survey in Asthma Identifies Oxidative Mechanism of Catalase Inactivation","volume":"176","author":"Ghosh","year":"2006","journal-title":"J. Immunol."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Bozinovski, S., Seow, H.J., Crack, P.J., Anderson, G.P., and Vlahos, R. (2012). Glutathione peroxidase-1 primes pro-inflammatory cytokine production after LPS challenge in vivo. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0033172"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1089\/ars.2009.2989","article-title":"Glutathione peroxidase 1 deficiency attenuates allergen-induced airway inflammation by suppressing th2 and th17 cell development","volume":"13","author":"Won","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/1440-1681.12522","article-title":"GPX1*Pro198Leu AND GPX3 rs2070593 as genetic risk markers for Italian asthmatic patients","volume":"43","author":"Iorio","year":"2016","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1089\/ars.2005.7.72","article-title":"The regulation and role of extracellular glutathione peroxidase","volume":"7","author":"Comhair","year":"2005","journal-title":"Antioxid. Redox Signal."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/thx.2005.053041","article-title":"Extracellular thioredoxin levels are increased in patients with acute lung injury","volume":"61","author":"Callister","year":"2006","journal-title":"Thorax"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0165-2478(03)00006-3","article-title":"Elevated serum levels of thioredoxin in patients with acute exacerbation of asthma","volume":"86","author":"Yamada","year":"2003","journal-title":"Immunol. Lett."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1165\/rcmb.2009-0136OC","article-title":"Ablation of glutaredoxin-1 attenuates lipopolysaccharide-induced lung inflammation and alveolar macrophage activation","volume":"44","author":"Aesif","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1183\/09031936.00115212","article-title":"Increased glutaredoxin-1 and decreased protein S-glutathionylation in sputum of asthmatics","volume":"41","author":"Kuipers","year":"2013","journal-title":"Eur. Respir. J."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"L528","DOI":"10.1152\/ajplung.00167.2012","article-title":"Genetic ablation of glutaredoxin-1 causes enhanced resolution of airways hyperresponsiveness and mucus metaplasia in mice with allergic airways disease","volume":"303","author":"Hoffman","year":"2012","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"L192","DOI":"10.1152\/ajplung.00426.2009","article-title":"Glutaredoxin 1 regulates cigarette smoke-mediated lung inflammation through differential modulation of I\u03baB kinases in mice: Impact on histone acetylation","volume":"299","author":"Chung","year":"2010","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Kuipers, I., Bracke, K.R., Brusselle, G.G., Aesif, S.W., Krijgsman, R., Arts, I.C., Wouters, E.F.M., and Reynaert, N.L. (2012). Altered cigarette smoke-induced lung inflammation due to Ablation of Grx1. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0038984"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/jcb.25017","article-title":"Thiol redox chemistry: Role of protein cysteine oxidation and altered redox homeostasis in allergic inflammation and asthma","volume":"116","author":"Hoffman","year":"2015","journal-title":"J. Cell. Biochem."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.jaci.2011.03.031","article-title":"Thiol redox disturbances in children with severe asthma are associated with posttranslational modification of the transcription factor nuclear factor (erythroid-derived 2)-like 2","volume":"127","author":"Fitzpatrick","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1164\/rccm.200803-380OC","article-title":"Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1","volume":"178","author":"Malhotra","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Liu, Q., Gao, Y., and Ci, X. (2019). Role of Nrf2 and its activators in respiratory diseases. Oxid. Med. Cell. Longev., 2019.","DOI":"10.1155\/2019\/7090534"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jaci.2016.06.054","article-title":"Acute asthma, prognosis, and treatment","volume":"139","author":"Fergeson","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jaip.2017.05.001","article-title":"Asthma Exacerbations: Pathogenesis, Prevention, and Treatment","volume":"5","author":"Castillo","year":"2017","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/pai.12566","article-title":"Genetic associations of the response to inhaled corticosteroids in children during an asthma exacerbation","volume":"27","author":"Keskin","year":"2016","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.lfs.2012.08.039","article-title":"Changes in NADPH oxidase mRNA level can be detected in blood at inhaled corticosteroid treated asthmatic children","volume":"91","author":"Endreffy","year":"2012","journal-title":"Life Sci."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s40265-019-01198-7","article-title":"Benefit:Risk Profile of Budesonide in Obstructive Airways Disease","volume":"79","author":"Tashkin","year":"2019","journal-title":"Drugs"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1067\/mai.2000.105319","article-title":"Airway mast cells and eosinophils correlate with clinical severity and airway hyperresponsiveness in corticosteroid-treated asthma","volume":"105","author":"Gibson","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2165\/00151829-200504050-00002","article-title":"Biomarkers predicting response to corticosteroid therapy in asthma","volume":"4","author":"Brightling","year":"2005","journal-title":"Treat. Respir. Med."},{"key":"ref_154","first-page":"PA1110","article-title":"Blood eosinophil dose response to oral corticosteroids in a population of patients with severe asthma","volume":"48","author":"Austin","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s40265-019-01202-0","article-title":"As-needed ICS-LABA in Mild Asthma: What Does the Evidence Say?","volume":"79","author":"Domingo","year":"2019","journal-title":"Drugs"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"e702","DOI":"10.1542\/peds.2006-3317","article-title":"Attenuation of the September epidemic of asthma exacerbations in children: A randomized, controlled trial of montelukast added to usual therapy","volume":"120","author":"Johnston","year":"2007","journal-title":"Pediatrics"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1801824","DOI":"10.1183\/13993003.01824-2018","article-title":"Tiotropium add-on therapy is safe and reduces seasonal worsening in paediatric asthma patients","volume":"53","author":"Vogelberg","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/07370016.2012.697844","article-title":"Impact of the Environment on Asthma Control","volume":"29","author":"Sterling","year":"2012","journal-title":"J. Community Health Nurs."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Donohue, J.F., Wise, R., Busse, W.W., Garfinkel, S., Zubek, V.B., Ghafouri, M., Manuel, R.C., Schlenker-Herceg, R., and Bleecker, E.R. (2016). Efficacy and safety of ipratropium bromide\/albuterol compared with albuterol in patients with moderate-to-severe asthma: A randomized controlled trial. BMC Pulm. Med., 16.","DOI":"10.1186\/s12890-016-0223-3"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/thx.2005.047803","article-title":"Anticholinergics in the treatment of children and adults with acute asthma: A systematic review with meta-analysis","volume":"60","author":"Rodrigo","year":"2005","journal-title":"Thorax"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1542\/peds.103.4.748","article-title":"Ipratropium bromide added to asthma treatment in the pediatric emergency department","volume":"103","author":"Zorc","year":"1999","journal-title":"Pediatrics"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1378\/chest.130.5.1301","article-title":"Rapid effects of inhaled corticosteroids in acute asthma: An evidence-based evaluation","volume":"130","author":"Rodrigo","year":"2006","journal-title":"Chest"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.rmed.2003.11.016","article-title":"Corticosteroid therapy for acute asthma","volume":"98","author":"Rowe","year":"2004","journal-title":"Respir. Med."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pulmoe.2019.10.006","article-title":"Chronic obstructive pulmonary disease and phenotypes: A state-of-the-art","volume":"26","author":"Corlateanu","year":"2020","journal-title":"Pulmonology"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"413735","DOI":"10.1155\/2013\/413735","article-title":"Inflammation and immune response in COPD: Where do we stand?","volume":"2013","author":"Rovina","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.tips.2006.08.001","article-title":"Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease","volume":"27","author":"Donnelly","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1042\/CS20160487","article-title":"Cellular and molecular mechanisms of asthma and COPD","volume":"131","author":"Barnes","year":"2017","journal-title":"Clin. Sci."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.4049\/jimmunol.168.9.4659","article-title":"Differential Roles of CC Chemokine Ligand 2\/Monocyte Chemotactic Protein-1 and CCR2 in the Development of T1 Immunity","volume":"168","author":"Traynor","year":"2002","journal-title":"J. Immunol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"6417415","DOI":"10.1155\/2018\/6417415","article-title":"Impact of Matrix Metalloproteinase 9 on COPD Development in Polish Patients: Genetic Polymorphism, Protein Level, and Their Relationship with Lung Function","volume":"2018","author":"Gilowska","year":"2018","journal-title":"BioMed Res. Int."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Dey, T., Kalita, J., Weldon, S., and Taggart, C. (2018). Proteases and Their Inhibitors in Chronic Obstructive Pulmonary Disease. J. Clin. Med., 7.","DOI":"10.3390\/jcm7090244"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2147\/COPD.S136592","article-title":"Th17 profile in COPD exacerbations","volume":"12","year":"2017","journal-title":"Int. J. COPD"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1042\/CS20100033","article-title":"Regulation in chronic obstructive pulmonary disease: The role of regulatory T-cells and Th17 cells","volume":"119","author":"Lane","year":"2010","journal-title":"Clin. Sci."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.chest.2017.12.017","article-title":"TGF-\u03b2 Signaling Pathways in Different Compartments of the Lower Airways of Patients With Stable COPD","volume":"153","author":"Sangiorgi","year":"2018","journal-title":"Chest"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1165\/rcmb.2014-0282RT","article-title":"Transforming growth factor-\u03b2 superfamily in obstructive lung diseases: More suspects than TGF-\u03b2 alone","volume":"52","author":"Verhamme","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12967-018-1635-z","article-title":"Roles of airway smooth muscle dysfunction in chronic obstructive pulmonary disease","volume":"16","author":"Yan","year":"2018","journal-title":"J. Transl. Med."},{"key":"ref_176","first-page":"3459","article-title":"Mechanisms of oxidative stress effects of the NADPH oxidase-ROS-NF-\u03baB transduction pathway and VPO1 on patients with chronic obstructive pulmonary disease combined with pulmonary hypertension","volume":"21","author":"Zhuan","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1586\/1744666X.2013.851347","article-title":"Neutrophils and emerging targets for treatment in chronic obstructive pulmonary disease","volume":"9","author":"Meijer","year":"2013","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_178","first-page":"PA931","article-title":"Lipid peroxidation in patients with COPD and chronic heart failure","volume":"52","author":"Klimanov","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3109\/15412555.2011.579202","article-title":"Plasma antioxidants are associated with impaired lung function and COPD exacerbations in smokers","volume":"8","author":"Nicks","year":"2011","journal-title":"COPD J. Chronic Obstr. Pulm. Dis."},{"key":"ref_180","first-page":"S130","article-title":"Does protease-antiprotease imbalance explain Chronic obstructive pulmonary disease?","volume":"13","author":"Lomas","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2147\/COPD.S10770","article-title":"Pathogenic triad in COPD: Oxidative stress, protease-antiprotease imbalance, and inflammation","volume":"6","author":"Fischer","year":"2011","journal-title":"Int. J. COPD"},{"key":"ref_182","first-page":"765","article-title":"Glutathione and nitrite levels in induced sputum at COPD patients and healthy smokers","volume":"6","author":"Turgut","year":"2014","journal-title":"J. Thorac. Dis."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1183\/09031936.04.00121203","article-title":"Manganese superoxide dismutase is increased in the airways of smokers\u2019 lungs","volume":"24","author":"Harju","year":"2004","journal-title":"Eur. Respir. J."},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"McGuinness, A., and Sapey, E. (2017). Oxidative Stress in COPD: Sources, Markers, and Potential Mechanisms. J. Clin. Med., 6.","DOI":"10.3390\/jcm6020021"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/thx.2007.086199","article-title":"Genetic variation and gene expression in antioxidant related enzymes and risk of COPD: A systematic review","volume":"63","author":"Bentley","year":"2008","journal-title":"Thorax"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/thx.2005.048512","article-title":"Functional variants of antioxidant genes in smokers with COPD and in those with normal lung function","volume":"61","author":"Young","year":"2006","journal-title":"Thorax"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1089\/ars.2019.7807","article-title":"Anti-allergic and anti-inflammatory effects and molecular mechanisms of thioredoxin on respiratory system diseases","volume":"32","author":"Zhou","year":"2020","journal-title":"Antioxid. Redox Signal."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1465-9921-7-133","article-title":"Modulation of glutaredoxin in the lung and sputum of cigarette smokers and chronic obstructive pulmonary disease","volume":"7","author":"Peltoniemi","year":"2006","journal-title":"Respir. Res."},{"key":"ref_189","first-page":"PA4216","article-title":"Activation of nuclear factor erythroid 2-related (Nrf2) system as a novel therapeutic approach in COPD","volume":"54","author":"Estornut","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1179559X1771912","DOI":"10.1177\/1179559X17719127","article-title":"Advances in chronic obstructive pulmonary disease therapy: A vascular-targeted approach","volume":"9","author":"Okpechi","year":"2017","journal-title":"Clin. Med. Insights Ther."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1164\/rccm.201701-0218PP","article-title":"Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary","volume":"195","author":"Vogelmeier","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Barratt, S., Creamer, A., Hayton, C., and Chaudhuri, N. (2018). Idiopathic Pulmonary Fibrosis (IPF): An Overview. J. Clin. Med., 7.","DOI":"10.3390\/jcm7080201"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.intimp.2013.06.034","article-title":"Neutrophil cell surface receptors and their intracellular signal transduction pathways","volume":"17","author":"Futosi","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-pathol-020712-164023","article-title":"The multifaceted functions of neutrophils","volume":"9","author":"Mayadas","year":"2014","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1615\/CritRevImmunol.v32.i6.10","article-title":"M1 and M2 macrophages: Oracles of health and disease","volume":"32","author":"Mills","year":"2012","journal-title":"Crit. Rev. Immunol."},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Schupp, J.C., Binder, H., J\u00e4ger, B., Cillis, G., Zissel, G., M\u00fcller-Quernheim, J., and Prasse, A. (2015). Macrophage activation in acute exacerbation of idiopathic pulmonary fibrosis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0116775"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1084\/jem.20162152","article-title":"Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span","volume":"214","author":"Misharin","year":"2017","journal-title":"J. Exp. Med."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S2213-2600(19)30050-5","article-title":"Can monocytes predict prognosis of idiopathic pulmonary fibrosis?","volume":"7","author":"Kreuter","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fmed.2018.00043","article-title":"The role of immune and inflammatory cells in idiopathic pulmonary fibrosis","volume":"5","author":"Desai","year":"2018","journal-title":"Front. Med."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12931-018-0798-8","article-title":"Fibrocytes are increased in lung and peripheral blood of patients with idiopathic pulmonary fibrosis","volume":"19","author":"Heukels","year":"2018","journal-title":"Respir. Res."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1183\/09059180.00007713","article-title":"Fibrocytes in pulmonary fibrosis: A brief synopsis","volume":"22","author":"Maharaj","year":"2013","journal-title":"Eur. Respir. Rev."},{"key":"ref_202","first-page":"174","article-title":"Are mast cells instrumental for fibrotic diseases?","volume":"4","author":"Rapley","year":"2014","journal-title":"Front. Pharmacol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12016-020-08779-5","article-title":"The Role of Mast Cells in IgE-Independent Lung Diseases","volume":"58","author":"Komi","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.4049\/jimmunol.176.10.5735","article-title":"Cutting Edge: Nonproliferating Mature Immune Cells Form a Novel Type of Organized Lymphoid Structure in Idiopathic Pulmonary Fibrosis","volume":"176","author":"Uzunhan","year":"2006","journal-title":"J. Immunol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/modpathol.2011.166","article-title":"The distribution of immunomodulatory cells in the lungs of patients with idiopathic pulmonary fibrosis","volume":"25","author":"Nuovo","year":"2012","journal-title":"Mod. Pathol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2147\/JIR.S40673","article-title":"Lymphocyte aggregates persist and accumulate in the lungs of patients with idiopathic pulmonary fibrosis","volume":"6","author":"Todd","year":"2013","journal-title":"J. Inflamm. Res."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the TH1\/TH2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nri.2017.118","article-title":"TH2 cell development and function","volume":"18","author":"Walker","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000073718","article-title":"Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro","volume":"132","author":"Saito","year":"2003","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"L92","DOI":"10.1152\/ajplung.2001.281.1.L92","article-title":"IL-12 attenuates bleomycin-induced pulmonary fibrosis","volume":"281","author":"Keane","year":"2001","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/pmic.200301007","article-title":"Cytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systematic sclerosis and idiopathic pulmonary fibrosis","volume":"5","author":"Rottoli","year":"2005","journal-title":"Proteomics"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.ajpath.2016.06.002","article-title":"Regulatory T Cells in Idiopathic Pulmonary Fibrosis: Too Much of a Good Thing?","volume":"186","author":"Moore","year":"2016","journal-title":"Am. J. Pathol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.bbadis.2012.11.021","article-title":"Oxidative stress and pulmonary fibrosis","volume":"1832","author":"Cheresh","year":"2013","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00441-016-2445-3","article-title":"Reactive oxygen species and fibrosis: Further evidence of a significant liaison","volume":"365","author":"Richter","year":"2016","journal-title":"Cell Tissue Res."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/157340810791233033","article-title":"TGF-\u03b2: Titan of Lung Fibrogenesis","volume":"6","author":"Yue","year":"2010","journal-title":"Curr. Enzym. Inhib."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.redox.2015.09.009","article-title":"Reciprocal regulation of TGF-\u03b2 and reactive oxygen species: A perverse cycle for fibrosis","volume":"6","author":"Liu","year":"2015","journal-title":"Redox Biol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.cellsig.2013.12.005","article-title":"Activation of NADPH oxidase subunit NCF4 induces ROS-mediated EMT signaling in HeLa cells","volume":"26","author":"Kim","year":"2014","journal-title":"Cell. Signal."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/thx.2009.113456","article-title":"NOX4\/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGF\u03b21-induced fibroblast differentiation into myofibroblasts","volume":"65","author":"Amara","year":"2010","journal-title":"Thorax"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/nm.2005","article-title":"NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury","volume":"15","author":"Hecker","year":"2009","journal-title":"Nat. Med."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"L661","DOI":"10.1152\/ajplung.00269.2005","article-title":"Transforming growth factor-\u03b21 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells","volume":"290","author":"Sturrock","year":"2006","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.04-2882fje","article-title":"Hydrogen peroxide is a diffusible paracrine signal for the induction of epithelial cell death by activated myofibroblasts","volume":"19","author":"Waghray","year":"2005","journal-title":"FASEB J."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/ars.2007.1914","article-title":"Transforming growth factor-\u03b2 activation in the lung: Focus on fibrosis and reactive oxygen species","volume":"10","author":"Koli","year":"2008","journal-title":"Antioxid. Redox Signal."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.freeradbiomed.2003.09.020","article-title":"Source of early reactive oxygen species in the apoptosis induced by transforming growth factor-\u03b2 in fetal rat hepatocytes","volume":"36","author":"Herrera","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12931-018-0754-7","article-title":"Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: A systematic review","volume":"19","author":"Fois","year":"2018","journal-title":"Respir. Res."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.resinv.2015.11.004","article-title":"Effect of inhaled N-acetylcysteine monotherapy on lung function and redox balance in idiopathic pulmonary fibrosis","volume":"54","author":"Muramatsu","year":"2016","journal-title":"Respir. Investig."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"L719","DOI":"10.1152\/ajplung.00058.2001","article-title":"Role of extracellular superoxide dismutase in bleomycin-induced pulmonary fibrosis","volume":"282","author":"Bowler","year":"2002","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0891-5849(03)00402-7","article-title":"Enhanced bleomycin-induced pulmonary damage in mice lacking extracellular superoxide dismutase","volume":"35","author":"Fattman","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12931-018-0933-6","article-title":"Role of SOD3 in silica-related lung fibrosis and pulmonary vascular remodeling","volume":"19","author":"Zelko","year":"2018","journal-title":"Respir. Res."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1165\/rcmb.2016-0153OC","article-title":"Superoxide dismutase 3 R213G single-nucleotide polymorphism blocks murine bleomycin-induced fibrosis and promotes resolution of inflammation","volume":"56","author":"Mouradian","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2559.2006.02470.x","article-title":"Extracellular superoxide dismutase has a highly specific localization in idiopathic pulmonary fibrosis\/usual interstitial pneumonia","volume":"49","author":"Kinnula","year":"2006","journal-title":"Histopathology"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/path.1435","article-title":"Expression of the thioredoxin system in interstitial lung disease","volume":"201","author":"Tiitto","year":"2003","journal-title":"J. Pathol."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.2169\/internalmedicine.49.4049","article-title":"Elevated levels of thioredoxin 1 in the lungs and sera of idiopathic pulmonary fibrosis, non-specific interstitial pneumonia and cryptogenic organizing pneumonia","volume":"49","author":"Iwata","year":"2010","journal-title":"Intern. Med."},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Richeldi, L., Davies, H.R.H.R., Spagnolo, P., and Luppi, F. (2003). Corticosteroids for idiopathic pulmonary fibrosis. Cochrane Database Syst. Rev., CD002880.","DOI":"10.1002\/14651858.CD002880"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1401739","article-title":"Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis","volume":"370","author":"Martinez","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","article-title":"Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis","volume":"366","author":"Raghu","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12931-018-0907-8","article-title":"Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis","volume":"19","author":"Yoon","year":"2018","journal-title":"Respir. Res."},{"key":"ref_239","doi-asserted-by":"crossref","unstructured":"Kistler, K.D., Nalysnyk, L., Rotella, P., and Esser, D. (2014). Lung transplantation in idiopathic pulmonary fibrosis: A systematic review of the literature. BMC Pulm. Med., 14.","DOI":"10.1186\/1471-2466-14-139"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.rmed.2018.12.015","article-title":"Inflammation and immunity in IPF pathogenesis and treatment","volume":"147","author":"Heukels","year":"2019","journal-title":"Respir. Med."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"1753466619847130","DOI":"10.1177\/1753466619847130","article-title":"High-flow nasal cannula oxygen therapy to treat acute respiratory failure in patients with acute exacerbation of idiopathic pulmonary fibrosis","volume":"13","author":"Vianello","year":"2019","journal-title":"Ther. Adv. Respir. Dis."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.bbadis.2011.12.012","article-title":"Oxidative stress and antioxidant therapy in cystic fibrosis","volume":"1822","author":"Galli","year":"2012","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_243","doi-asserted-by":"crossref","unstructured":"Chatterjee, S. (2016). Oxidative Stress, Inflammation, and Disease. Oxidative Stress and Biomaterials, Elsevier.","DOI":"10.1016\/B978-0-12-803269-5.00002-4"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0140-6736(93)92422-P","article-title":"Pathogenesis of cystic fibrosis","volume":"341","author":"Koch","year":"1993","journal-title":"Lancet"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jcf.2015.03.003","article-title":"Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy","volume":"14","author":"Cantin","year":"2015","journal-title":"J. Cyst. Fibros."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"e00019-18","DOI":"10.1128\/CMR.00019-18","article-title":"Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis","volume":"31","author":"Parkins","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ccm.2015.10.003","article-title":"The Microbiome in Cystic Fibrosis","volume":"37","author":"Huang","year":"2016","journal-title":"Clin. Chest Med."},{"key":"ref_248","first-page":"OA4401","article-title":"Presence of mucus plugging is predictive of long term lung function in children with cystic fibrosis","volume":"50","author":"Turkovic","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.biocel.2014.01.017","article-title":"Current concepts of immune dysregulation in cystic fibrosis","volume":"52","author":"Rieber","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1002\/ppul.23242","article-title":"Inflammation and its genesis in cystic fibrosis","volume":"50","author":"Nichols","year":"2015","journal-title":"Pediatr. Pulmonol."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12275-018-7545-1","article-title":"Antimicrobial actions of dual oxidases and lactoperoxidase","volume":"56","author":"Sarr","year":"2018","journal-title":"J. Microbiol."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000136357","article-title":"Oxidative innate immune defenses by Nox\/Duox Family NADPH oxidases","volume":"15","author":"Rada","year":"2008","journal-title":"Contrib. Microbiol."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/jac\/dku357","article-title":"Combination of hypothiocyanite and lactoferrin (ALX-109) enhances the ability of tobramycin and aztreonam to eliminate Pseudomonas aeruginosa biofilms growing on cystic fibrosis airway epithelial cells","volume":"70","author":"Coutermarsh","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s12010-016-2327-x","article-title":"Comparative Analysis of the Antiviral Activity of Camel, Bovine, and Human Lactoperoxidases Against Herpes Simplex Virus Type 1","volume":"182","author":"Uversky","year":"2017","journal-title":"Appl. Biochem. Biotechnol."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1164\/rccm.200607-1029OC","article-title":"A novel host defense system of airways is defective in cystic fibrosis","volume":"175","author":"Moskwa","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jcf.2005.05.008","article-title":"Nitric oxide in cystic fibrosis","volume":"4","year":"2005","journal-title":"J. Cyst. Fibros."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/(SICI)1099-0496(199709)24:3<173::AID-PPUL2>3.0.CO;2-O","article-title":"Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis","volume":"24","author":"Grasemann","year":"1997","journal-title":"Pediatr. Pulmonol."},{"key":"ref_258","doi-asserted-by":"crossref","unstructured":"Causer, A.J., Shute, J.K., Cummings, M.H., Shepherd, A.I., Gruet, M., Costello, J.T., Bailey, S., Lindley, M., Pearson, C., and Connett, G. (2020). Circulating biomarkers of antioxidant status and oxidative stress in people with cystic fibrosis: A systematic review and meta-analysis. Redox Biol., 101436.","DOI":"10.1016\/j.redox.2020.101436"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1073\/pnas.1010721108","article-title":"Thiol peroxidases mediate specific genome-wide regulation of gene expression in response to hydrogen peroxide","volume":"108","author":"Fomenko","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_260","first-page":"15","article-title":"Antioxidant therapies in COPD","volume":"1","author":"Rahman","year":"2006","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1165\/rcmb.2014-0263OC","article-title":"Oxidative stress regulates CFTR gene expression in human airway epithelial cells through a distal antioxidant response element","volume":"52","author":"Zhang","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_262","doi-asserted-by":"crossref","unstructured":"Chen, J., Kinter, M., Shank, S., Cotton, C., Kelley, T.J., and Ziady, A.G. (2008). Dysfunction of Nrf-2 in CF epithelia leads to excess intracellular H2O2 and inflammatory cytokine production. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0003367"},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/S0891-5849(01)00530-5","article-title":"Rethinking cystic fibrosis pathology: The critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation","volume":"30","author":"Hudson","year":"2001","journal-title":"Free Radic. Biol. Med."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/IJGM.S15618","article-title":"Role of glutathione in immunity and inflammation in the lung","volume":"4","author":"Ghezzi","year":"2011","journal-title":"Int. J. Gen. Med."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10863-018-9748-x","article-title":"Aberrant GSH reductase and NOX activities concur with defective CFTR to pro-oxidative imbalance in cystic fibrosis airways","volume":"50","author":"Favia","year":"2018","journal-title":"J. Bioenerg. Biomembr."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1183\/09031936.00170213","article-title":"Oxidation contributes to low glutathione in the airways of children with cystic fibrosis","volume":"44","author":"Kettle","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/0884533610374198","article-title":"Update in pediatrics: Focus on fat-soluble vitamins","volume":"25","author":"Sathe","year":"2010","journal-title":"Nutr. Clin. Pract."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ajcn\/80.1.3","article-title":"The ABCs of vitamin E and \u03b2-carotene absorption","volume":"80","author":"Traber","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/ajcn\/80.2.374","article-title":"Antioxidant deficiency in cystic fibrosis: When is the right time to take action?","volume":"80","author":"Back","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0968-0004(02)00003-8","article-title":"Structure, mechanism and regulation of peroxiredoxins","volume":"28","author":"Wood","year":"2003","journal-title":"Trends Biochem. Sci."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3945\/ajcn.2009.27757","article-title":"Association of cholesterol oxidation and abnormalities in fatty acid metabolism in cystic fibrosis","volume":"90","author":"Iuliano","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jcf.2017.04.015","article-title":"Pulmonary surfactant dysfunction in pediatric cystic fibrosis: Mechanisms and reversal with a lipid-sequestering drug","volume":"16","author":"Gunasekara","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.2165\/00003495-200363220-00015","article-title":"Inhaled Tobramycin (TOBI\u00ae): A Review of its Use in the Management of Pseudomonas aeruginosa Infections in Patients with Cystic Fibrosis","volume":"63","author":"Cheer","year":"2003","journal-title":"Drugs"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"a009779","DOI":"10.1101\/cshperspect.a009779","article-title":"Antibiotic and anti-inflammatory therapies for cystic fibrosis","volume":"3","author":"Chmiel","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1513\/AnnalsATS.201812-863OT","article-title":"Developing inhaled antibiotics in cystic fibrosis: Current challenges and opportunities","volume":"16","author":"Nichols","year":"2019","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1378\/chest.121.1.55","article-title":"Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis","volume":"121","author":"Moss","year":"2002","journal-title":"Chest"},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcf.2010.10.003","article-title":"Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial","volume":"10","author":"Konstan","year":"2011","journal-title":"J. Cyst. Fibros."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ppul.24269","article-title":"Optimization of colistin dosing regimen for cystic fibrosis patients with chronic Pseudomonas aeruginosa biofilm lung infections","volume":"54","author":"Hengzhuang","year":"2019","journal-title":"Pediatr. Pulmonol."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/MCP.0b013e32831311e8","article-title":"Ibuprofen therapy for cystic fibrosis lung disease: Revisited","volume":"14","author":"Konstan","year":"2008","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_280","doi-asserted-by":"crossref","unstructured":"Lands, L.C., and Stanojevic, S. (1999). Oral non-steroidal anti-inflammatory drug therapy for cystic fibrosis. Cochrane Database Syst. Rev., CD001505.","DOI":"10.1002\/14651858.CD001505"},{"key":"ref_281","first-page":"386","article-title":"Lung deposition after electronically breath-controlled inhalation and manually triggered conventional inhalation in cystic fibrosis patients","volume":"18","author":"Sollich","year":"2005","journal-title":"J. Aerosol Med. Depos. Clear. Eff. Lung"},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ppul.10117","article-title":"Effects of salmeterol on arterial oxyhemoglobin saturations in patients with cystic fibrosis","volume":"34","author":"Salvatore","year":"2002","journal-title":"Pediatr. Pulmonol."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1164\/ajrccm.153.5.8630593","article-title":"Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis","volume":"153","author":"Robinson","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1067\/mpd.2001.118570","article-title":"A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities","volume":"139","author":"Quan","year":"2001","journal-title":"J. Pediatr."},{"key":"ref_285","first-page":"CD001127","article-title":"Dornase alfa for cystic fibrosis","volume":"2018","author":"Yang","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"9188","DOI":"10.1073\/pnas.87.23.9188","article-title":"Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum","volume":"87","author":"Shak","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1001\/jama.1992.03480140073036","article-title":"Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study","volume":"267","author":"Aitken","year":"1992","journal-title":"JAMA"},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1056\/NEJM199203193261207","article-title":"A preliminary study of aerosolized recombinant human deoxyribonuclease i in the treatment of cystic fibrosis","volume":"326","author":"Hubbard","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"ref_289","first-page":"CD002768","article-title":"Physical exercise training for cystic fibrosis","volume":"2017","author":"Radtke","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_290","first-page":"CD006842","article-title":"Oscillating devices for airway clearance in people with cystic fibrosis","volume":"2020","author":"Morrison","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/14728214.2019.1591369","article-title":"Emerging drugs for treating the acute respiratory distress syndrome","volume":"24","author":"Shaw","year":"2019","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","article-title":"Dexamethasone treatment for the acute respiratory distress syndrome: A multicentre, randomised controlled trial","volume":"8","author":"Villar","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s13063-016-1456-4","article-title":"Evaluating the efficacy of dexamethasone in the treatment of patients with persistent acute respiratory distress syndrome: Study protocol for a randomized controlled trial","volume":"17","author":"Villar","year":"2016","journal-title":"Trials"},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/CCM.0000000000002284","article-title":"Randomized clinical trial of a combination of an inhaled corticosteroid and beta agonist in patients at risk of developing the acute respiratory distress syndrome","volume":"45","author":"Festic","year":"2017","journal-title":"Crit. Care Med."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S2213-2600(17)30188-1","article-title":"Clinical trials in acute respiratory distress syndrome: Challenges and opportunities","volume":"5","author":"Matthay","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"ref_296","unstructured":"(2020, May 02). NCT03096314 Vitamin D to Improve Outcomes by Leveraging Early Treatment, Available online: https:\/\/clinicaltrials.gov\/show\/NCT03096314."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"e1128","DOI":"10.1097\/CCM.0000000000003405","article-title":"Vitamin D to Prevent Lung Injury Following Esophagectomy-A Randomized, Placebo-Controlled Trial","volume":"46","author":"Parekh","year":"2018","journal-title":"Crit. Care Med."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1056\/NEJMoa1911124","article-title":"Early high-dose Vitamin D3 for critically ill, Vitamin D\u2013deficient patients","volume":"381","author":"Ginde","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s13054-015-1091-6","article-title":"Aspirin as a potential treatment in sepsis or acute respiratory distress syndrome","volume":"19","author":"Toner","year":"2015","journal-title":"Crit. Care"},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/CCM.0b013e31826ab38b","article-title":"Antiplatelet therapy is associated with decreased transfusion-associated risk of lung dysfunction, multiple organ failure, and mortality in trauma patients","volume":"41","author":"Harr","year":"2013","journal-title":"Crit. Care Med."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/thoraxjnl-2016-208571","article-title":"Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS","volume":"72","author":"Hamid","year":"2017","journal-title":"Thorax"},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S2213-2600(18)30418-1","article-title":"Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): A randomised phase 2a safety trial","volume":"7","author":"Matthay","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"L20","DOI":"10.1152\/ajplung.00300.2011","article-title":"Mechanisms of attenuation of abdominal sepsis induced acute lung injury by ascorbic acid","volume":"303","author":"Fisher","year":"2012","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_304","unstructured":"(2020, September 20). NCT02106975 Vitamin C Infusion for Treatment in Sepsis Induced Acute Lung Injury\u2014Full Text View\u2014ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/show\/NCT02106975."},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.11825","article-title":"Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients with Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial","volume":"322","author":"Fowler","year":"2019","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"R180","DOI":"10.1186\/cc9286","article-title":"Nebulized heparin is associated with fewer days of mechanical ventilation in critically ill patients: A randomized controlled trial","volume":"14","author":"Dixon","year":"2010","journal-title":"Crit. Care"},{"key":"ref_307","unstructured":"(2020, September 25). ACTRN12612000418875 A Multi-Centre Randomised, Placebo Controlled Trial of Nebulised Heparin in Patients with or at Risk of Developing Acute Respiratory Distress Syndrome, to Determine if Nebulised Heparin Improves Long Term Physical Function. Australian New Zealand Clinical Trials Registry. Available online: https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=362354."},{"key":"ref_308","doi-asserted-by":"crossref","unstructured":"Morris, P.E., Steingrub, J.S., Huang, B.Y., Tang, S., Liu, P.M., Rhode, P.R., and Wong, H.C. (2012). A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome. BMC Pulm. Med., 12.","DOI":"10.1186\/1471-2466-12-5"},{"key":"ref_309","unstructured":"(2020, May 02). NCT00879606 Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome\u2014Full Text View\u2014ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/show\/NCT00879606."},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1097\/00003246-200007000-00064","article-title":"Inhibition of p38 mitogen activate kinase attenuates the severity of pancreatitis-induced adult respiratory distress syndrome","volume":"28","author":"Denham","year":"2000","journal-title":"Crit. Care Med."},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1097\/CCM.0000000000001132","article-title":"A Randomized Dose-Escalation Study of the Safety and Anti-Inflammatory Activity of the p38 Mitogen-Activated Protein Kinase Inhibitor Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome","volume":"43","author":"Christie","year":"2015","journal-title":"Crit. Care Med."},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s40560-014-0067-y","article-title":"Effect of a selective neutrophil elastase inhibitor on mortality and ventilator-free days in patients with increased extravascular lung water: A post hoc analysis of the PiCCO Pulmonary Edema Study","volume":"2","author":"Tagami","year":"2014","journal-title":"J. Intensive Care"},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/resp.12969","article-title":"Efficacy of early sivelestat administration on acute lung injury and acute respiratory distress syndrome","volume":"22","author":"Kido","year":"2017","journal-title":"Respirology"},{"key":"ref_314","doi-asserted-by":"crossref","unstructured":"Pu, S., Wang, D., Liu, D., Zhao, Y., Qi, D., He, J., and Zhou, G. (2017). Effect of sivelestat sodium in patients with acute lung injury or acute respiratory distress syndrome: A meta-analysis of randomized controlled trials. BMC Pulm. Med., 17.","DOI":"10.1186\/s12890-017-0498-z"},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.etp.2010.11.011","article-title":"Protective effect of Ulinastatin against murine models of sepsis: Inhibition of TNF-\u03b1 and IL-6 and augmentation of IL-10 and IL-13","volume":"64","author":"Cao","year":"2012","journal-title":"Exp. Toxicol. Pathol."},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"34","DOI":"10.5492\/wjccm.v3.i1.34","article-title":"Ulinastatin for acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis","volume":"3","author":"Leng","year":"2014","journal-title":"World J. Crit. Care Med."},{"key":"ref_317","unstructured":"(2020, May 02). NCT02895191 The Safety and Dose Response Relationship of Ulinastatin for Acute Respiratory Distress Syndrome(ARDS)\u2014Full Text View\u2014ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/show\/NCT02895191."},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/CCM.0b013e31822d7bf0","article-title":"A randomized Trial of recombinant human granulocyte-macrophage colony stimulating factor for Patients with acute lung injury","volume":"40","author":"Paine","year":"2012","journal-title":"Crit. Care Med."},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.4049\/jimmunol.164.10.5439","article-title":"Effect of CD14 Blockade in Rabbits with Escherichia coli Pneumonia and Sepsis","volume":"164","author":"Frevert","year":"2000","journal-title":"J. Immunol."},{"key":"ref_320","unstructured":"(2020, May 02). NCT03017547 A Phase 2 Study of IC14 in Acute Respiratory Distress Syndrome\u2014Full Text View\u2014ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/show\/NCT03017547."},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1378\/chest.14-3161","article-title":"The use of inhaled prostaglandins in patients with ARDS: A systematic review and meta-analysis","volume":"147","author":"Fuller","year":"2015","journal-title":"Chest"},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1096\/fj.13-236380","article-title":"Extracellular histones are essential effectors of C5aR- and C5L2-mediated tissue damage and inflammation in acute lung injury","volume":"27","author":"Bosmann","year":"2013","journal-title":"FASEB J."},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1182\/blood-2013-07-514984","article-title":"Nonanticoagulant heparin prevents histone-mediated cytotoxicity in vitro and improves survival in sepsis","volume":"123","author":"Wildhagen","year":"2014","journal-title":"Blood"},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1517\/13543784.17.3.349","article-title":"The future of the IL-1 receptor antagonist anakinra: From rheumatoid arthritis to adult-onset still\u2019s disease and systemic-onset juvenile idiopathic arthritis","volume":"17","author":"Kalliolias","year":"2008","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10928-011-9219-z","article-title":"Population pharmacokinetic-pharmacodynamic-disease progression model for effects of anakinra in Lewis rats with collagen-induced arthritis","volume":"38","author":"Liu","year":"2011","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"2476824","DOI":"10.1155\/2018\/2476824","article-title":"Alternative and Natural Therapies for Acute Lung Injury and Acute Respiratory Distress Syndrome","volume":"2018","author":"Patel","year":"2018","journal-title":"Biomed Res. Int."},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4187\/respcare.06322","article-title":"Current and emerging biologic therapies for asthma and copd","volume":"63","author":"Wechsler","year":"2018","journal-title":"Respir. Care"},{"key":"ref_328","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1002\/alr.21611","article-title":"Asthma treatments: New and emerging therapies","volume":"5","author":"Calhoun","year":"2015","journal-title":"Int. Forum Allergy Rhinol."},{"key":"ref_329","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.trsl.2015.08.004","article-title":"Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease","volume":"167","author":"Durham","year":"2016","journal-title":"Transl. Res."},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2147\/COPD.S152291","article-title":"Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease","volume":"13","author":"Tashkin","year":"2018","journal-title":"Int. J. COPD"},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1067\/mai.2003.49","article-title":"Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma","volume":"111","author":"Corren","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_332","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jaci.2014.10.026","article-title":"Biomarker-based asthma phenotypes of corticosteroid response","volume":"135","author":"Cowan","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3109\/02770903.2014.910221","article-title":"Biologic therapy in asthma: Entering the new age of personalized medicine","volume":"51","author":"Fajt","year":"2014","journal-title":"J. Asthma"},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaci.2014.10.050","article-title":"Advances in adult asthma diagnosis and treatment in 2014","volume":"135","author":"Apter","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_335","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_336","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/all.14048","article-title":"Update: Mepolizumab treatment in patients with severe eosinophilic asthma and prior omalizumab use","volume":"75","author":"Albers","year":"2020","journal-title":"Allergy Eur. J. Allergy Clin. Immunol."},{"key":"ref_337","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1164\/rccm.200208-789OC","article-title":"Eosinophil\u2019s role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway","volume":"167","author":"Kay","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_338","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jaci.2013.11.026","article-title":"Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis","volume":"133","author":"Haldar","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_339","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S2213-2600(15)00042-9","article-title":"Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: Results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"3","author":"Castro","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"ref_340","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1001\/jama.2014.5052","article-title":"Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: The VIDA randomized clinical trial","volume":"311","author":"Castro","year":"2014","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_341","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12931-019-1251-3","article-title":"The effectiveness of Reslizumab in severe asthma treatment: A real-world experience","volume":"20","author":"Ibrahim","year":"2019","journal-title":"Respir. Res."},{"key":"ref_342","doi-asserted-by":"crossref","first-page":"e000494","DOI":"10.1136\/bmjresp-2019-000494","article-title":"Reslizumab as add-on therapy in patients with refractory asthma","volume":"7","author":"McDonald","year":"2020","journal-title":"BMJ Open Respir. Res."},{"key":"ref_343","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s40265-018-0876-8","article-title":"Benralizumab: First Global Approval","volume":"78","author":"Markham","year":"2018","journal-title":"Drugs"},{"key":"ref_344","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/1744666X.2017.1316194","article-title":"Benralizumab for the treatment of asthma","volume":"13","author":"Saco","year":"2017","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_345","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting \u03b22-agonists (SIROCCO): A randomised, multicentre, placebo-controlled phase 3 trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet"},{"key":"ref_346","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1056\/NEJMoa1703501","article-title":"Oral glucocorticoid-sparing effect of benralizumab in severe asthma","volume":"376","author":"Nair","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_347","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s40265-017-0768-3","article-title":"Dupilumab: First Global Approval","volume":"77","author":"Shirley","year":"2017","journal-title":"Drugs"},{"key":"ref_348","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","article-title":"Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma","volume":"378","author":"Rabe","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_349","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_350","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S2213-2600(16)30265-X","article-title":"Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): Replicate, phase 3, randomised, double-blind, placebo-controlled trials","volume":"4","author":"Hanania","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"ref_351","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S2213-2600(15)00197-6","article-title":"Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: A randomised, double-blind, placebo-controlled, phase 2b trial","volume":"3","author":"Brightling","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"ref_352","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.rmed.2017.12.006","article-title":"Efficacy and safety of lebrikizumab in adult patients with mild-to-moderate asthma not receiving inhaled corticosteroids","volume":"134","author":"Korenblat","year":"2018","journal-title":"Respir. Med."},{"key":"ref_353","doi-asserted-by":"crossref","first-page":"1800948","DOI":"10.1183\/13993003.00948-2018","article-title":"Tralokinumab did not demonstrate oral corticosteroid-sparing effects in severe asthma","volume":"53","author":"Busse","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_354","unstructured":"(2020, May 02). NCT03927157 Study to Evaluate Tezepelumab in Adults With Severe Uncontrolled Asthma\u2014Full Text View\u2014ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/show\/NCT03927157."},{"key":"ref_355","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/13543784.2019.1672657","article-title":"Tezepelumab: A novel biological therapy for the treatment of severe uncontrolled asthma","volume":"28","author":"Marone","year":"2019","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_356","doi-asserted-by":"crossref","unstructured":"Ding, W., Zou, G.L., Zhang, W., Lai, X.N., Chen, H.W., and Xiong, L.X. (2018). Interleukin-33: Its emerging role in allergic diseases. Molecules, 23.","DOI":"10.3390\/molecules23071665"},{"key":"ref_357","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1164\/rccm.201212-2318OC","article-title":"Study of Brodalumab, a Human Anti \u2013 IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma","volume":"188","author":"Busse","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_358","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1365-2222.2012.04014.x","article-title":"Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: A randomized, placebo-controlled clinical trial","volume":"42","author":"Nair","year":"2012","journal-title":"Clin. Exp. Allergy"},{"key":"ref_359","unstructured":"(2020, May 02). NCT00632502 Neutrophilic Asthma Study With Navarixin (MK-7123, SCH 527123) (MK-7123-017)(COMPLETED)\u2014Full Text View\u2014ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/show\/NCT00632502."},{"key":"ref_360","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1111\/j.1365-2222.2011.03816.x","article-title":"TPI ASM8 reduces eosinophil progenitors in sputum after allergen challenge","volume":"41","author":"Imaoka","year":"2011","journal-title":"Clin. Exp. Allergy"},{"key":"ref_361","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1056\/NEJMoa1613125","article-title":"KIT inhibition by imatinib in patients with severe refractory asthma","volume":"376","author":"Cahill","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_362","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/thx.2005.045260","article-title":"Tumour necrosis factor (TNF\u03b1) as a novel therapeutic target in symptomatic corticosteroid dependent asthma","volume":"60","author":"Howarth","year":"2005","journal-title":"Thorax"},{"key":"ref_363","first-page":"640","article-title":"Etanercept in chronic severe asthma","volume":"61","author":"Oliveri","year":"2006","journal-title":"Thorax"},{"key":"ref_364","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1183\/09031936.00063510","article-title":"Efficacy and safety of etanercept in moderate-to-severe asthma: A randomised, controlled trial","volume":"37","author":"Holgate","year":"2011","journal-title":"Eur. Respir. J."},{"key":"ref_365","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/thx.2007.086314","article-title":"The role of a soluble TNF\u03b1 receptor fusion protein (etanercept) in corticosteroid refractory asthma: A double blind, randomised, placebo controlled trial","volume":"63","author":"Morjaria","year":"2008","journal-title":"Thorax"},{"key":"ref_366","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5320\/wjr.v7.i1.17","article-title":"Advance of antioxidants in asthma treatment","volume":"7","author":"Zhu","year":"2017","journal-title":"World J. Respirol."},{"key":"ref_367","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0891-5849(90)90076-U","article-title":"The physiological role of zinc as an antioxidant","volume":"8","author":"Bray","year":"1990","journal-title":"Free Radic. Biol. Med."},{"key":"ref_368","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1096\/fasebj.1.6.3315807","article-title":"Free radical tissue damage: Protective role of antioxidant nutrients","volume":"1","author":"Machlin","year":"1987","journal-title":"FASEB J."},{"key":"ref_369","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3945\/ajcn.111.032623","article-title":"Manipulating antioxidant intake in asthma: A randomized controlled trial1-3","volume":"96","author":"Wood","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_370","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1139\/apnm-2016-0335","article-title":"Does chronic physical activity level modify the airway inflammatory response to an acute bout of exercise in the postprandial period?","volume":"42","author":"Kurti","year":"2017","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"ref_371","first-page":"184","article-title":"Preventive effect of N-acetylcysteine in a mouse model of steroid resistant acute exacerbation of asthma","volume":"12","author":"Eftekhari","year":"2013","journal-title":"EXCLI J."},{"key":"ref_372","unstructured":"(2020, May 02). NCT02605824 Clinical Trial of NAC in Asthma\u2014Full Text View\u2014ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/show\/NCT02605824."},{"key":"ref_373","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.acthis.2016.07.001","article-title":"Sakuranetin reverses vascular peribronchial and lung parenchyma remodeling in a murine model of chronic allergic pulmonary inflammation","volume":"118","author":"Sakoda","year":"2016","journal-title":"Acta Histochem."},{"key":"ref_374","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/bph.12062","article-title":"Flavonone treatment reverses airway inflammation and remodelling in an asthma murine model","volume":"168","author":"Toledo","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_375","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12931-015-0211-9","article-title":"Astragalin inhibits autophagy-associated airway epithelial fibrosis","volume":"16","author":"Cho","year":"2015","journal-title":"Respir. Res."},{"key":"ref_376","doi-asserted-by":"crossref","unstructured":"Cho, I.H., Gong, J.H., Kang, M.K., Lee, E.J., Park, J.H.Y., Park, S.J., and Kang, Y.H. (2014). Astragalin inhibits airway eotaxin-1 induction and epithelial apoptosis through modulating oxidative stress-responsive MAPK signaling. BMC Pulm. Med., 14.","DOI":"10.1186\/1471-2466-14-122"},{"key":"ref_377","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.intimp.2016.06.017","article-title":"Therapy with resveratrol attenuates obesity-associated allergic airway inflammation in mice","volume":"38","author":"Calixto","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"ref_378","doi-asserted-by":"crossref","first-page":"17296","DOI":"10.1038\/s41598-017-17558-w","article-title":"High-fat diet-induced obesity impairs insulin signaling in lungs of allergen-challenged mice: Improvement by resveratrol","volume":"7","author":"Calixto","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_379","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/1874467212666190102105052","article-title":"Therapeutic Potential of Morin in Ovalbumin-induced Allergic Asthma Via Modulation of SUMF2\/IL-13 and BLT2\/NF-kB Signaling Pathway","volume":"12","author":"Kandhare","year":"2019","journal-title":"Curr. Mol. Pharmacol."},{"key":"ref_380","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jep.2015.06.049","article-title":"Evaluation of anti-asthmatic and antioxidant potential of Boerhavia procumbens in toluene diisocyanate (TDI) treated rats","volume":"172","author":"Bokhari","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"ref_381","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4162\/nrp.2015.9.6.579","article-title":"Sonchus asper extract inhibits LPS-induced oxidative stress and pro-inflammatory cytokine production in RAW264.7 macrophages","volume":"9","author":"Wang","year":"2015","journal-title":"Nutr. Res. Pract."},{"key":"ref_382","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000441061","article-title":"Esculentoside a attenuates allergic airway inflammation via activation of the Nrf-2 pathway","volume":"167","author":"Ci","year":"2015","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_383","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1089\/jmf.2011.1609","article-title":"Capsicum annuum L. methanolic extract inhibits ovalbumin-induced airway inflammation and oxidative stress in a mouse model of asthma","volume":"14","author":"Jang","year":"2011","journal-title":"J. Med. Food"},{"key":"ref_384","doi-asserted-by":"crossref","unstructured":"Sahreen, S., Khan, M.R., Khan, R.A., and Alkreathy, H.M. (2014). Cardioprotective role of leaves extracts of Carissa opaca against CCl 4 induced toxicity in rats. BMC Res. Notes, 7.","DOI":"10.1186\/1756-0500-7-224"},{"key":"ref_385","doi-asserted-by":"crossref","unstructured":"Bouch, S., Harding, R., O\u2019Reilly, M., Wood, L.G., and Sozo, F. (2016). Impact of dietary tomato juice on changes in pulmonary oxidative stress, inflammation and structure induced by neonatal hyperoxia in mice (Mus musculus). PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0159633"},{"key":"ref_386","doi-asserted-by":"crossref","unstructured":"Pigati, P.A., Righetti, R.F., Possa, S.S., Romanholo, B.S., Rodrigues, A.P.D., dos Santos, A.S.A., Xisto, D.G., Antunes, M.A., Prado, C.M., and Leick, E.A. (2015). Y-27632 is associated with corticosteroid-potentiated control of pulmonary remodeling and inflammation in guinea pigs with chronic allergic inflammation. BMC Pulm. Med., 15.","DOI":"10.1186\/s12890-015-0073-4"},{"key":"ref_387","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.resp.2013.12.012","article-title":"Effects of Rho-kinase inhibition in lung tissue with chronic inflammation","volume":"192","author":"Righetti","year":"2014","journal-title":"Respir. Physiol. Neurobiol."},{"key":"ref_388","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2466-13-52","article-title":"Modulation of the oscillatory mechanics of lung tissue and the oxidative stress response induced by arginase inhibition in a chronic allergic inflammation model","volume":"13","author":"Aristoteles","year":"2013","journal-title":"BMC Pulm. Med."},{"key":"ref_389","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.intimp.2016.07.009","article-title":"Increased glutathione levels contribute to the beneficial effects of hydrogen sulfide and inducible nitric oxide inhibition in allergic lung inflammation","volume":"39","author":"Campos","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"ref_390","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/jcmm.12197","article-title":"Poly(ADP-ribose) polymerase inhibition with HYDAMTIQ reduces allergen-induced asthma-like reaction, bronchial hyper-reactivity and airway remodelling","volume":"18","author":"Lucarini","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"ref_391","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.taap.2016.06.026","article-title":"Activation of angiotensin-converting enzyme 2 (ACE2) attenuates allergic airway inflammation in rat asthma model","volume":"306","author":"Dhawale","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_392","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1021\/acs.jafc.5b04861","article-title":"Protective Effects of Diallyl Sulfide on Ovalbumin-Induced Pulmonary Inflammation of Allergic Asthma Mice by MicroRNA-144, -34a, and -34b\/c-Modulated Nrf2 Activation","volume":"64","author":"Ho","year":"2016","journal-title":"J. Agric. Food Chem."},{"key":"ref_393","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1038\/emm.2016.35","article-title":"S-adenosylmethionine reduces airway inflammation and fibrosis in a murine model of chronic severe asthma via suppression of oxidative stress","volume":"48","author":"Yoon","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"ref_394","doi-asserted-by":"crossref","first-page":"787561","DOI":"10.1155\/2015\/787561","article-title":"Pituitary Adenylate Cyclase-Activating Polypeptide Reverses Ammonium Metavanadate-Induced Airway Hyperresponsiveness in Rats","volume":"2015","author":"Tlili","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_395","doi-asserted-by":"crossref","first-page":"250725","DOI":"10.1155\/2013\/250725","article-title":"Blockade of airway inflammation by kaempferol via disturbing Tyk-STAT signaling in airway epithelial cells and in asthmatic mice","volume":"2013","author":"Gong","year":"2013","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"ref_396","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3892\/ol.2013.1365","article-title":"Quercetin liposomes protect against radiation-induced pulmonary injury in a murine model","volume":"6","author":"Liu","year":"2013","journal-title":"Oncol. Lett."},{"key":"ref_397","doi-asserted-by":"crossref","first-page":"427","DOI":"10.5114\/aoms.2015.50975","article-title":"Quercetin protects against lipopolysaccharide-induced acute lung injury in rats through suppression of inflammation and oxidative stress","volume":"11","author":"Huang","year":"2015","journal-title":"Arch. Med. Sci."},{"key":"ref_398","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000438993","article-title":"The Suppressive Effect of Quercetin on Toll-Like Receptor 7-Mediated Activation in Alveolar Macrophages","volume":"96","author":"Yasui","year":"2015","journal-title":"Pharmacology"},{"key":"ref_399","first-page":"15028297","article-title":"Quercetin ameliorates LPS-induced inflammation in human peripheral blood mononuclear cells by inhibition of the TLR2-NF-\u03baB pathway","volume":"15","author":"Zhang","year":"2016","journal-title":"Genet. Mol. Res."},{"key":"ref_400","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4110\/in.2016.16.3.165","article-title":"Immunomodulatory effects of ambroxol on airway hyperresponsiveness and inflammation","volume":"16","author":"Takeda","year":"2016","journal-title":"Immune Netw."},{"key":"ref_401","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.pupt.2014.07.007","article-title":"5-Aminosalicylic Acid attenuates allergen-induced airway inflammation and oxidative stress in asthma","volume":"29","author":"Raju","year":"2014","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_402","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.intimp.2015.08.043","article-title":"Inhibition of airway inflammation and remodeling by sitagliptin in murine chronic asthma","volume":"29","author":"Nader","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"ref_403","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000438705","article-title":"Assessment of the Mechanistic Role of Cinnarizine in Modulating Experimentally-Induced Bronchial Asthma in Rats","volume":"96","author":"Messiha","year":"2015","journal-title":"Pharmacology"},{"key":"ref_404","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1056\/NEJMoa1708208","article-title":"Mepolizumab for eosinophilic chronic obstructive pulmonary disease","volume":"377","author":"Pavord","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_405","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/17476348.2019.1561287","article-title":"Mepolizumab for the prevention of chronic obstructive pulmonary disease exacerbations","volume":"13","author":"Beros","year":"2019","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_406","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMoa1905248","article-title":"Benralizumab for the prevention of COPD exacerbations","volume":"381","author":"Criner","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_407","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S2213-2600(14)70187-0","article-title":"Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: A randomised, double-blind, placebo-controlled, phase 2a study","volume":"2","author":"Brightling","year":"2014","journal-title":"Lancet Respir. Med."},{"key":"ref_408","unstructured":"(2020, May 02). NCT02138916 Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History\u2014Full Text View\u2014ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/show\/NCT02138916."},{"key":"ref_409","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrd4025","article-title":"New anti-inflammatory targets for chronic obstructive pulmonary disease","volume":"12","author":"Barnes","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_410","unstructured":"(2020, September 25). Global Initiative for Chronic Obstructive Lung Disease: Pocket Guide To COPD Diagnosis, Management, and Prevention, A Guide for Health Care Professionals. Available online: https:\/\/goldcopd.org\/wp-content\/uploads\/2016\/12\/wms-GOLD-2017-Pocket-Guide.pdf."},{"key":"ref_411","first-page":"CD002991","article-title":"Inhaled corticosteroids for stable chronic obstructive pulmonary disease","volume":"2012","author":"Yang","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_412","first-page":"CD003794","article-title":"Combined corticosteroid and long-acting beta2-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease","volume":"2017","author":"Nannini","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_413","doi-asserted-by":"crossref","first-page":"101855","DOI":"10.1016\/j.pupt.2019.101855","article-title":"Impact of ICS\/LABA and LABA\/LAMA FDCs on functional and clinical outcomes in COPD: A network meta-analysis","volume":"59","author":"Calzetta","year":"2019","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_414","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jaci.2012.12.1564","article-title":"Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease","volume":"131","author":"Barnes","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_415","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1164\/rccm.201405-0992OC","article-title":"CXCR2 antagonist MK-7123 a phase 2 proof-of-concept trial for chronic obstructive pulmonary disease","volume":"191","author":"Rennard","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_416","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/14728222.2019.1667976","article-title":"COPD: Preclinical models and emerging therapeutic targets","volume":"23","author":"Barreiro","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_417","doi-asserted-by":"crossref","unstructured":"Paul, T., Salazar-Degracia, A., Peinado, V.I., Tura-Ceide, O., Blanco, I., Barreiro, E., and Barber\u00e0, J.A. (2018). Soluble guanylate cyclase stimulation reduces oxidative stress in experimental Chronic Obstructive Pulmonary Disease. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0190628"},{"key":"ref_418","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/jcp.25241","article-title":"Therapeutic Approaches in Mitochondrial Dysfunction, Proteolysis, and Structural Alterations of Diaphragm and Gastrocnemius in Rats With Chronic Heart Failure","volume":"231","author":"Barreiro","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"ref_419","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/17476348.2018.1526677","article-title":"Therapeutic targets for inflammation-mediated airway remodeling in chronic lung disease","volume":"12","author":"Brasier","year":"2018","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_420","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ejmech.2018.04.006","article-title":"Discovery of potent and selective BRD4 inhibitors capable of blocking TLR3-induced acute airway inflammation","volume":"151","author":"Liu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_421","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1021\/acs.jmedchem.6b01761","article-title":"Drug Discovery Targeting Bromodomain-Containing Protein 4","volume":"60","author":"Liu","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_422","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/thoraxjnl-2017-210672","article-title":"Mesenchymal stromal cells: A novel therapy for the treatment of chronic obstructive pulmonary disease?","volume":"73","author":"Broekman","year":"2018","journal-title":"Thorax"},{"key":"ref_423","doi-asserted-by":"crossref","first-page":"170071","DOI":"10.1183\/16000617.0071-2017","article-title":"Pharmacotherapy for idiopathic pulmonary fibrosis: Current landscape and future potential","volume":"26","author":"Raghu","year":"2017","journal-title":"Eur. Respir. Rev."},{"key":"ref_424","doi-asserted-by":"crossref","unstructured":"Margaritopoulos, G.A., Trachalaki, A., Wells, A.U., Vasarmidi, E., Bibaki, E., Papastratigakis, G., Detorakis, S., Tzanakis, N., and Antoniou, K.M. (2018). Pirfenidone improves survival in IPF: Results from a real-life study. BMC Pulm. Med., 18.","DOI":"10.1186\/s12890-018-0736-z"},{"key":"ref_425","doi-asserted-by":"crossref","first-page":"190021","DOI":"10.1183\/16000617.0021-2019","article-title":"The therapy of idiopathic pulmonary fibrosis: What is next?","volume":"28","author":"Somogyi","year":"2019","journal-title":"Eur. Respir. Rev."},{"key":"ref_426","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic Pulmonary Fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_427","doi-asserted-by":"crossref","unstructured":"Murray, L.A., Rosada, R., Moreira, A.P., Joshi, A., Kramer, M.S., Hesson, D.P., Argentieri, R.L., Mathai, S., Gulati, M., and Herzog, E.L. (2010). Serum amyloid P therapeutically attenuates murine bleomycin-induced pulmonary fibrosis via its effects on macrophages. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0009683"},{"key":"ref_428","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.exer.2011.08.015","article-title":"Monocyte development inhibitor PRM-151 decreases corneal myofibroblast generation in rabbits","volume":"93","author":"Santhiago","year":"2011","journal-title":"Exp. Eye Res."},{"key":"ref_429","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1183\/13993003.00850-2015","article-title":"Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: Safety, pharmacokinetics and exploratory efficacy","volume":"47","author":"Dillingh","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_430","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1001\/jama.2018.6129","article-title":"Effect of recombinant human pentraxin 2 vs placebo on change in forced vital capacity in patients with idiopathic pulmonary fibrosis a randomized clinical trial","volume":"319","author":"Raghu","year":"2018","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_431","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S2213-2600(19)30172-9","article-title":"Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: An open-label extension study","volume":"7","author":"Raghu","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"ref_432","unstructured":"(2020, September 20). NCT01890265 Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF)\u2014Full Text View\u2014ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/show\/NCT01890265."},{"key":"ref_433","first-page":"OA3400","article-title":"PRAISE, a randomized, placebo-controlled, double-blind Phase 2 clinical trial of pamrevlumab (FG-3019) in IPF patients","volume":"50","author":"Gorina","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_434","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.ajpath.2018.01.009","article-title":"A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors: GPR40 and GPR84","volume":"188","author":"Gagnon","year":"2018","journal-title":"Am. J. Pathol."},{"key":"ref_435","doi-asserted-by":"crossref","first-page":"1800663","DOI":"10.1183\/13993003.00663-2018","article-title":"Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis","volume":"53","author":"Khalil","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_436","unstructured":"(2020, September 20). NCT02738801 Study to Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of GLPG1690, Available online: https:\/\/clinicaltrials.gov\/show\/NCT02738801."},{"key":"ref_437","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S2213-2600(18)30181-4","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): A phase 2a randomised placebo-controlled trial","volume":"6","author":"Maher","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_438","doi-asserted-by":"crossref","first-page":"e000422","DOI":"10.1136\/bmjresp-2019-000422","article-title":"Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2)","volume":"6","author":"Maher","year":"2019","journal-title":"BMJ Open Respir. Res."},{"key":"ref_439","first-page":"1841","article-title":"University of Michigan Health Sys-tem, 6301 MSRB III, 1150 W. Medical Cen-ter Dr","volume":"357","author":"Henderson","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_440","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1183\/09031936.00143708","article-title":"Effects of a leukotriene B4 receptor antagonist on bleomycin-induced pulmonary fibrosis","volume":"34","author":"Izumo","year":"2009","journal-title":"Eur. Respir. J."},{"key":"ref_441","unstructured":"(2020, September 20). NCT02503657 Safety and Tolerability Study in Subjects With Idiopathic Pulmonary Fibrosis (IPF)\u2014Full Text View\u2014ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/show\/NCT02503657."},{"key":"ref_442","unstructured":"(2020, September 20). NCT02688647 A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Idiopathic Pulmonary Fibrosis, Available online: https:\/\/clinicaltrials.gov\/show\/NCT02688647."},{"key":"ref_443","doi-asserted-by":"crossref","first-page":"16814","DOI":"10.1073\/pnas.1414189111","article-title":"Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism","volume":"111","author":"Weiss","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_444","unstructured":"(2020, September 20). NCT03142191 A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis\u2014Full Text View\u2014ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/show\/NCT03142191."},{"key":"ref_445","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40169-016-0117-2","article-title":"JNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markers","volume":"5","author":"Ye","year":"2016","journal-title":"Clin. Transl. Med."},{"key":"ref_446","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.200706-805OC","article-title":"Partial inhibition of integrin \u03b1v\u03b26 prevents pulmonary fibrosis without exacerbating inflammation","volume":"177","author":"Horan","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_447","unstructured":"(2020, September 20). NCT01371305 STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)\u2014Full Text View\u2014ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/show\/NCT01371305."},{"key":"ref_448","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.3892\/mmr.2016.5960","article-title":"PI3K\/Akt signaling is involved in the pathogenesis of bleomycin-induced pulmonary fibrosis via regulation of epithelial-mesenchymal transition","volume":"14","author":"Zhang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_449","unstructured":"(2020, September 20). NCT01725139 A Proof of Mechanism Study With GSK2126458 in Patients With Idiopathic Pulmonary Fibrosis (IPF)\u2014Full Text View\u2014ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/show\/NCT01725139."},{"key":"ref_450","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/thoraxjnl-2015-207429","article-title":"Exploration of a potent PI3 kinase\/mTOR inhibitor as a novel anti-fibrotic agent in IPF","volume":"71","author":"Mercer","year":"2016","journal-title":"Thorax"},{"key":"ref_451","doi-asserted-by":"crossref","first-page":"1801992","DOI":"10.1183\/13993003.01992-2018","article-title":"A randomised, placebo-controlled study of omipalisib (PI3K\/mTOR) in idiopathic pulmonary fibrosis","volume":"53","author":"Lukey","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_452","unstructured":"(2020, September 20). NCT01462006 Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF), Available online: https:\/\/clinicaltrials.gov\/show\/NCT01462006."},{"key":"ref_453","unstructured":"(2020, September 20). NCT01969409 Autoantibody Reduction Therapy in Patients With Idiopathic Pulmonary Fibrosis, Available online: https:\/\/clinicaltrials.gov\/show\/NCT01969409."},{"key":"ref_454","unstructured":"(2020, September 20). NCT01266317 Combined PEX, Rituximab and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations\u2014Full Text View\u2014ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/show\/NCT01266317."},{"key":"ref_455","doi-asserted-by":"crossref","unstructured":"Donahoe, M., Valentine, V.G., Chien, N., Gibson, K.F., Raval, J.S., Saul, M., Xue, J., Zhang, Y., and Duncan, S.R. (2015). Autoantibody-targeted treatments for acute exacerbations of idiopathic pulmonary fibrosis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0133684"},{"key":"ref_456","unstructured":"(2020, September 20). NCT01777737 Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole, Available online: https:\/\/clinicaltrials.gov\/show\/nct01777737."},{"key":"ref_457","unstructured":"(2020, September 20). NCT01872689 A Study of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis\u2014Full Text View\u2014ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/show\/NCT01872689."},{"key":"ref_458","unstructured":"(2020, September 20). NCT01629667 A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults With Idiopathic Pulmonary Fibrosis\u2014Full Text View\u2014ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/show\/NCT01629667."},{"key":"ref_459","unstructured":"(2020, September 20). NCT02173145 Azithromycin in Idiopathic Pulmonary Fibrosis\u2014Full Text View\u2014ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/show\/NCT02173145."},{"key":"ref_460","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/13543784.2018.1492548","article-title":"Senolytic drugs in respiratory medicine: Is it an appropriate therapeutic approach?","volume":"27","author":"Cazzola","year":"2018","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_461","doi-asserted-by":"crossref","unstructured":"Malayeri, A.R., Hemmati, A.A., Arzi, A., Rezaie, A., Ghafurian-Boroojerdnia, M., and Khalili, H.R. (2016). A comparison of the effects of quercetin hydrate with those of vitamin E on the levels of IL-13, PDGF, TNF-\u03b1, and INF- \u03b3 in bleomycin-induced pulmonary fibrosis in rats. Jundishapur J. Nat. Pharm. Prod., 11.","DOI":"10.17795\/jjnpp-27705"},{"key":"ref_462","doi-asserted-by":"crossref","first-page":"14532","DOI":"10.1038\/ncomms14532","article-title":"Cellular senescence mediates fibrotic pulmonary disease","volume":"8","author":"Schafer","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_463","doi-asserted-by":"crossref","first-page":"1602367","DOI":"10.1183\/13993003.02367-2016","article-title":"Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo","volume":"50","author":"Lehmann","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_464","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1172\/JCI68782","article-title":"Type 2 alveolar cells are stem cells in adult lung","volume":"123","author":"Barkauskas","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_465","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1164\/rccm.200810-1615OC","article-title":"Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis","volume":"181","author":"Sisson","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_466","doi-asserted-by":"crossref","unstructured":"Martyanov, V., Kim, G.H.J., Hayes, W., Du, S., Ganguly, B.J., Sy, O., Lee, S.K., Bogatkevich, G.S., Schieven, G.L., and Schiopu, E. (2017). Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0187580"},{"key":"ref_467","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1172\/JCI86249","article-title":"Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension","volume":"126","author":"Guignabert","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_468","doi-asserted-by":"crossref","first-page":"1701360","DOI":"10.1183\/13993003.01360-2017","article-title":"Licence to kill senescent cells in idiopathic pulmonary fibrosis?","volume":"50","author":"Mailleux","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_469","doi-asserted-by":"crossref","first-page":"250","DOI":"10.7603\/s40730-015-0010-4","article-title":"Therapeutic use of fisetin, curcumin, and mesoporous carbon nanoparticle loaded fisetin in bleomycin-induced idiopathic pulmonary fibrosis","volume":"2","author":"Banerjee","year":"2015","journal-title":"Biomed. Res. Ther."},{"key":"ref_470","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ijrobp.2017.02.216","article-title":"Inhibition of Bcl-2\/xl With ABT-263 Selectively Kills Senescent Type II Pneumocytes and Reverses Persistent Pulmonary Fibrosis Induced by Ionizing Radiation in Mice","volume":"99","author":"Pan","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_471","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ebiom.2018.12.052","article-title":"Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study","volume":"40","author":"Justice","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_472","doi-asserted-by":"crossref","first-page":"7234","DOI":"10.1038\/s41598-019-43652-2","article-title":"A Systematic Review of the Clinical Efficacy and Safety of CFTR Modulators in Cystic Fibrosis","volume":"9","author":"Habib","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_473","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jcf.2018.05.004","article-title":"CFTR modulator theratyping: Current status, gaps and future directions","volume":"18","author":"Clancy","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"ref_474","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3389\/fphar.2019.01662","article-title":"CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine","volume":"10","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_475","first-page":"275","article-title":"CFTR modulators: Shedding light on precision medicine for cystic fibrosis","volume":"7","year":"2016","journal-title":"Front. Pharmacol."},{"key":"ref_476","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jcf.2017.08.013","article-title":"Therapeutic approaches to CFTR dysfunction: From discovery to drug development","volume":"17","author":"Li","year":"2018","journal-title":"J. Cyst. Fibros."},{"key":"ref_477","doi-asserted-by":"crossref","first-page":"18843","DOI":"10.1073\/pnas.1105787108","article-title":"Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809","volume":"108","author":"Hadida","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_478","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S2213-2600(17)30215-1","article-title":"Efficacy and safety of lumacaftor and ivacaftor in patients aged 6\u201311 years with cystic fibrosis homozygous for F508del-CFTR: A randomised, placebo-controlled phase 3 trial","volume":"5","author":"Ratjen","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"ref_479","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S2213-2600(16)30427-1","article-title":"Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): A phase 3, extension study","volume":"5","author":"Konstan","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"ref_480","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa1409547","article-title":"Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for phe508del CFTR","volume":"373","author":"Wainwright","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_481","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/17476348.2018.1512409","article-title":"Emerging pharmacotherapies in cystic fibrosis","volume":"12","author":"McElvaney","year":"2018","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_482","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1172\/JCI24898","article-title":"Small-molecule correctors of defective \u0394F508-CFTR cellular processing identified by high-throughput screening","volume":"115","author":"Pedemonte","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_483","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1124\/mol.115.099689","article-title":"Potentiators of defective DF508-CFTR gating that do not interfere with corrector action","volume":"88","author":"Phuan","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"ref_484","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/2472630317692561","article-title":"High-Throughput Screening for Readthrough Modulators of CFTR PTC Mutations","volume":"22","author":"Liang","year":"2017","journal-title":"SLAS Technol."},{"key":"ref_485","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/2472555217729790","article-title":"Use of a High-Throughput Phenotypic Screening Strategy to Identify Amplifiers, a Novel Pharmacological Class of Small Molecules That Exhibit Functional Synergy with Potentiators and Correctors","volume":"23","author":"Giuliano","year":"2018","journal-title":"SLAS Discov."},{"key":"ref_486","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1021\/acs.jmedchem.7b01288","article-title":"Discovery of N-(3-Carbamoyl-5,5,7,7-tetramethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-2-yl)-lH-pyrazole-5-carboxamide (GLPG1837), a Novel Potentiator Which Can Open Class III Mutant Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channels to a High","volume":"61","author":"Kelgtermans","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_487","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1038\/s41591-018-0200-x","article-title":"Structure-guided combination therapy to potently improve the function of mutant CFTRs","volume":"24","author":"Veit","year":"2018","journal-title":"Nat. Med."},{"key":"ref_488","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1021\/acs.jmedchem.7b01339","article-title":"Discovery of 4-[(2R,4R)-4-({[1-(2,2-Difluoro-1,3-benzodioxol-5-yl)cyclopropyl]carbonyl}amino)-7-(difluoromethoxy)-3,4-dihydro-2H-chromen-2-yl]benzoic Acid (ABBV\/GLPG-2222), a Potent Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Corrector for","volume":"61","author":"Wang","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_489","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1177\/2472555219849375","article-title":"High-Throughput Surface Liquid Absorption and Secretion Assays to Identify F508del CFTR Correctors Using Patient Primary Airway Epithelial Cultures","volume":"24","author":"Berg","year":"2019","journal-title":"SLAS Discov."},{"key":"ref_490","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3389\/fphar.2019.00514","article-title":"Identification of GLPG\/ABBV-2737, a novel class of corrector, which exerts functional synergy with other CFTR modulators","volume":"10","author":"Gees","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_491","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.stemcr.2019.04.014","article-title":"High-Throughput Screening for Modulators of CFTR Activity Based on Genetically Engineered Cystic Fibrosis Disease-Specific iPSCs","volume":"12","author":"Merkert","year":"2019","journal-title":"Stem Cell Rep."},{"key":"ref_492","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12967-017-1193-9","article-title":"Cystic fibrosis: Current therapeutic targets and future approaches","volume":"15","author":"Rafeeq","year":"2017","journal-title":"J. Transl. Med."},{"key":"ref_493","first-page":"CD000407","article-title":"Oral steroids for long-term use in cystic fibrosis","volume":"2015","author":"Cheng","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_494","first-page":"CD001915","article-title":"Inhaled corticosteroids for cystic fibrosis","volume":"2019","author":"Welch","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_495","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00148581-200911020-00002","article-title":"The role of inhaled corticosteroids in the management of cystic fibrosis","volume":"11","author":"Ross","year":"2009","journal-title":"Pediatr. Drugs"},{"key":"ref_496","first-page":"CD001505","article-title":"Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis","volume":"2019","author":"Lands","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_497","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1513\/AnnalsATS.201706-486OC","article-title":"Association of high-dose ibuprofen use, lung function decline, and long-term survival in children with cystic fibrosis","volume":"15","author":"Konstan","year":"2018","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_498","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jcf.2013.12.009","article-title":"A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis","volume":"13","author":"Konstan","year":"2014","journal-title":"J. Cyst. Fibros."},{"key":"ref_499","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/cts.12426","article-title":"Phase I Studies of Acebilustat: Pharmacokinetics, Pharmacodynamics, Food Effect, and CYP3A Induction","volume":"10","author":"Elborn","year":"2017","journal-title":"Clin. Transl. Sci."},{"key":"ref_500","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cct.2018.07.014","article-title":"EMPIRE-CF: A phase II randomized placebo-controlled trial of once-daily, oral acebilustat in adult patients with cystic fibrosis\u2014Study design and patient demographics","volume":"72","author":"Elborn","year":"2018","journal-title":"Contemp. Clin. Trials"},{"key":"ref_501","unstructured":"(2020, May 03). NCT02759562 Effect of Andecaliximab on FEV1 in Adults With Cystic Fibrosis\u2014Full Text View\u2014ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/show\/NCT02759562."},{"key":"ref_502","unstructured":"(2020, May 03). NCT03748199 Clinical Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of POL6014 in Patients with CF\u2014Full Text View\u2014ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/show\/NCT03748199."},{"key":"ref_503","first-page":"S191","article-title":"Alpha-1 antitrypsin therapy in cystic fibrosis and the lung disease associated with alpha-1 antitrypsin deficiency","volume":"13","author":"McElvaney","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_504","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1183\/09031936.00194611","article-title":"Efficacy, safety and effect on biomarkers of AZD9668 in cystic fibrosis","volume":"40","author":"Elborn","year":"2012","journal-title":"Eur. Respir. J."},{"key":"ref_505","unstructured":"Motwani, M., Bennett, F., Tepper, M., White, B., Norris, P., MacAllister, R., Serhan, C., and Gilroy, D. (2017). Anabasum (JBT-101) enhances resolution of inflammation in humans. Arthritis Rheumatol., 69, Available online: https:\/\/acrabstracts.org\/abstract\/anabasum-jbt-101-enhances-resolution-of-inflammation-in-humans\/."},{"key":"ref_506","unstructured":"(2020, September 20). NCT02465450 Safety, Tolerability, Pharmacokinetics, and Efficacy of JBT-101 (Lenabasum) in Cystic Fibrosis\u2014Full Text View\u2014ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02465450."},{"key":"ref_507","doi-asserted-by":"crossref","first-page":"e00394","DOI":"10.1002\/prp2.394","article-title":"Ajulemic acid: Potential treatment for chronic inflammation","volume":"6","author":"Burstein","year":"2018","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_508","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-20825-1_1","article-title":"Endocannabinoids and their pharmacological actions","volume":"Volume 231","author":"Pertwee","year":"2015","journal-title":"Handbook of Experimental Pharmacology"},{"key":"ref_509","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/sj.bjp.0707320","article-title":"Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells","volume":"151","author":"Gkoumassi","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_510","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/0140-6736(91)91167-S","article-title":"Aerosol \u03b11 -antitrypsin treatment for cystic fibrosis","volume":"337","author":"McElvaney","year":"1991","journal-title":"Lancet"},{"key":"ref_511","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1183\/09031936.00047306","article-title":"\u03b11-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients","volume":"29","author":"Griese","year":"2007","journal-title":"Eur. Respir. J."},{"key":"ref_512","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/089426803321919889","article-title":"Characteristics of EPI-hNE4 aerosol: A new elastase inhibitor for treatment of cystic fibrosis","volume":"16","author":"Grimbert","year":"2003","journal-title":"J. Aerosol Med. Depos. Clear. Eff. Lung"},{"key":"ref_513","first-page":"314","article-title":"Hydroxychloroquine\u2014Pilot study of anti-inflammatory effects in cystic fibrosis","volume":"43","author":"Williams","year":"2008","journal-title":"Pediatr. Pulmonol."},{"key":"ref_514","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jcf.2012.08.016","article-title":"Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis","volume":"12","author":"Moss","year":"2013","journal-title":"J. Cyst. Fibros."},{"key":"ref_515","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1053\/rmed.2002.1471","article-title":"Low-dose methotrexate for advanced pulmonary disease in patients with cystic fibrosis","volume":"97","author":"Ballmann","year":"2003","journal-title":"Respir. Med."},{"key":"ref_516","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1165\/rcmb.2018-0145ED","article-title":"Targeting IL-8 in cystic fibrosis: Enough but not too much","volume":"59","author":"McElvaney","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_517","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.molimm.2014.10.013","article-title":"The effect of the decoy molecule PA401 on CXCL8 levels in bronchoalveolar lavage fluid of patients with cystic fibrosis","volume":"63","author":"McElvaney","year":"2015","journal-title":"Mol. Immunol."},{"key":"ref_518","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ni1056","article-title":"Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway","volume":"5","author":"Karp","year":"2004","journal-title":"Nat. Immunol."},{"key":"ref_519","doi-asserted-by":"crossref","first-page":"13266","DOI":"10.1073\/pnas.202296999","article-title":"Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-\u03baB and AP-1 activation, and IL-8 gene expression in human leukocytes","volume":"99","author":"Zouki","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_520","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.4049\/jimmunol.176.5.3044","article-title":"An Antimicrobial Cathelicidin Peptide, Human CAP18\/LL-37, Suppresses Neutrophil Apoptosis via the Activation of Formyl-Peptide Receptor-Like 1 and P2X 7","volume":"176","author":"Nagaoka","year":"2006","journal-title":"J. Immunol."},{"key":"ref_521","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1128\/IAI.02444-14","article-title":"Impact of resolvin E1 on murine neutrophil phagocytosis in type 2 diabetes","volume":"83","author":"Herrera","year":"2015","journal-title":"Infect. Immun."},{"key":"ref_522","doi-asserted-by":"crossref","first-page":"718","DOI":"10.4049\/jimmunol.1601543","article-title":"Neutrophil Resolvin E1 Receptor Expression and Function in Type 2 Diabetes","volume":"198","author":"Freire","year":"2017","journal-title":"J. Immunol."},{"key":"ref_523","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1096\/fj.12-219519","article-title":"Resolvin D2 restores neutrophil directionality and improves survival after burns","volume":"27","author":"Kurihara","year":"2013","journal-title":"FASEB J."},{"key":"ref_524","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nature05877","article-title":"Resolvin E1 and protectin D1 activate inflammation-resolution programmes","volume":"447","author":"Schwab","year":"2007","journal-title":"Nature"},{"key":"ref_525","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.4049\/jimmunol.1400313","article-title":"Resolvin D1 Attenuates Polyinosinic-Polycytidylic Acid\u2013Induced Inflammatory Signaling in Human Airway Epithelial Cells via TAK1","volume":"193","author":"Hsiao","year":"2014","journal-title":"J. Immunol."},{"key":"ref_526","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jcf.2017.11.017","article-title":"Resolvin D1 regulates epithelial ion transport and inflammation in cystic fibrosis airways","volume":"17","author":"Ringholz","year":"2018","journal-title":"J. Cyst. Fibros."},{"key":"ref_527","unstructured":"(2020, May 03). NCT03265288 Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults\u2014Full Text View\u2014ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/show\/NCT03265288."},{"key":"ref_528","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/13543784.2019.1631284","article-title":"Prospects for the introduction of targeted antioxidant drugs for the prevention and treatment of diseases related to free radical pathology","volume":"28","author":"Kontoghiorghes","year":"2019","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_529","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1164\/rccm.201805-0872ED","article-title":"Low-hanging fruit and antioxidant therapy in cystic fibrosis","volume":"198","author":"Cantin","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_530","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jcf.2014.09.014","article-title":"Randomized, single blind, controlled trial of inhaled glutathione vs placebo in patients with cystic fibrosis","volume":"14","author":"Calabrese","year":"2015","journal-title":"J. Cyst. Fibros."},{"key":"ref_531","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jcf.2014.09.015","article-title":"The effect of short-term, high-dose oral N-acetylcysteine treatment on oxidative stress markers in cystic fibrosis patients with chronic P. aeruginosa infection\u2014A pilot study","volume":"14","author":"Skov","year":"2015","journal-title":"J. Cyst. Fibros."},{"key":"ref_532","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1183\/09031936.00038114","article-title":"Oxidative stress in cystic fibrosis lung disease: An early event, but worth targeting?","volume":"44","author":"Hector","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_533","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1164\/rccm.201303-0427OC","article-title":"Inhalation treatment with glutathione in patients with cystic fibrosis: A randomized clinical trial","volume":"188","author":"Griese","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_534","first-page":"CD006751","article-title":"Vitamin A and beta (\u03b2)-carotene supplementation for cystic fibrosis","volume":"2018","author":"Chang","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_535","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez Jim\u00e9nez, D., D\u00edaz Mart\u00edn, J.J., Arias Llorente, R.P., and Bouso\u00f1o Garc\u00eda, C. (2015). Oxidative Stress in Cystic Fibrosis. Cystic Fibrosis in the Light of New Research, IntechOpen.","DOI":"10.5772\/60661"},{"key":"ref_536","doi-asserted-by":"crossref","first-page":"862","DOI":"10.2741\/4253","article-title":"Antioxidant targeting by deferiprone in diseases related to oxidative damage","volume":"19","author":"Kontoghiorghe","year":"2014","journal-title":"Front. Biosci. Landmark"},{"key":"ref_537","first-page":"161","article-title":"Prospects for introducing deferiprone as potent pharmaceutical antioxidant","volume":"1","author":"Kontoghiorghes","year":"2009","journal-title":"Front. Biosci. Elit."},{"key":"ref_538","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jcf.2014.08.008","article-title":"Long-term treatment with oral N-acetylcysteine: Affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial","volume":"14","author":"Conrad","year":"2015","journal-title":"J. Cyst. Fibros."},{"key":"ref_539","first-page":"341","article-title":"Vitamin E supplementation in cystic fibrosis","volume":"22","author":"Peters","year":"1996","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_540","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/MCP.0b013e3283136787","article-title":"Update on fat-soluble vitamins in cystic fibrosis","volume":"14","author":"Maqbool","year":"2008","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_541","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/biof.75","article-title":"Present trends in vitamin E research","volume":"36","author":"Galli","year":"2010","journal-title":"BioFactors"},{"key":"ref_542","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.freeradbiomed.2008.04.037","article-title":"\u03b3-Tocopherol nebulization by a lipid aerosolization device improves pulmonary function in sheep with burn and smoke inhalation injury","volume":"45","author":"Hamahata","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"ref_543","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/03639040802248798","article-title":"Development of \u03b1-tocopherol acetate nanoparticles: Influence of preparative processes","volume":"35","author":"Anais","year":"2009","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_544","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000012818","article-title":"Long-term oral \u03b2-carotene supplementation in patients with cystic fibrosis\u2014Effects on antioxidative status and pulmonary function","volume":"44","author":"Rust","year":"2000","journal-title":"Ann. Nutr. Metab."},{"key":"ref_545","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jcf.2010.09.005","article-title":"Effect of an antioxidant-rich multivitamin supplement in cystic fibrosis","volume":"10","author":"Sagel","year":"2011","journal-title":"J. Cyst. Fibros."},{"key":"ref_546","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jcf.2007.05.001","article-title":"A pilot study on the safety and efficacy of a novel antioxidant rich formulation in patients with cystic fibrosis","volume":"7","author":"Papas","year":"2008","journal-title":"J. Cyst. Fibros."},{"key":"ref_547","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1164\/rccm.201801-0105OC","article-title":"Effects of an antioxidant-enriched multivitamin in cystic fibrosis","volume":"198","author":"Sagel","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_548","first-page":"383","article-title":"Selenium and vitamin E in cystic fibrosis","volume":"45","author":"Foucaud","year":"1988","journal-title":"Arch. Fr. Pediatr."},{"key":"ref_549","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/jnci\/djn512","article-title":"Selenium and vitamin E: Cell type- and intervention-specific tissue effects in prostate cancer","volume":"101","author":"Tsavachidou","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_550","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/ajcn\/65.6.1858","article-title":"Plasma vitamin C concentrations in patients with cystic fibrosis: Evidence of associations with lung inflammation","volume":"65","author":"Ellemunter","year":"1997","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_551","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000129650","article-title":"The effect of zinc supplements in cystic fibrosis patients","volume":"52","author":"Robberecht","year":"2008","journal-title":"Ann. Nutr. Metab."},{"key":"ref_552","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-079X.2009.00726.x","article-title":"Melatonin improves sleep and reduces nitrite in the exhaled breath condensate in cystic fibrosis\u2014A randomized, double-blind placebo-controlled study","volume":"48","author":"Cunha","year":"2010","journal-title":"J. Pineal Res."},{"key":"ref_553","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ppul.20152","article-title":"Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung disease","volume":"39","author":"Moss","year":"2005","journal-title":"Pediatr. Pulmonol."},{"key":"ref_554","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1183\/09031936.99.13107199","article-title":"ICAM-1 mediates lung leukocyte recruitment but not pulmonary fibrosis in a murine model of bleomycin-induced lung injury","volume":"13","author":"Matsuse","year":"1999","journal-title":"Eur. Respir. J."},{"key":"ref_555","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.4049\/jimmunol.170.4.2106","article-title":"IL-17, Produced by Lymphocytes and Neutrophils, Is Necessary for Lipopolysaccharide-Induced Airway Neutrophilia: IL-15 as a Possible Trigger","volume":"170","author":"Ferretti","year":"2003","journal-title":"J. Immunol."},{"key":"ref_556","doi-asserted-by":"crossref","first-page":"28181","DOI":"10.1074\/jbc.M303141200","article-title":"Troglitazone antagonizes tumor necrosis factor-\u03b1-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-\u03baB","volume":"278","author":"Ruan","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_557","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-4419-9072-3_22","article-title":"A paradigm for gene regulation: Inflammation, NF-\u03baB and PPAR","volume":"544","author":"Vermeulen","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_558","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.4049\/jimmunol.171.12.6827","article-title":"Peroxisome Proliferator Activator Receptor-\u03b3 Ligands, 15-Deoxy-\u0394 12,14 -Prostaglandin J 2 and Ciglitazone, Reduce Systemic Inflammation in Polymicrobial Sepsis by Modulation of Signal Transduction Pathways","volume":"171","author":"Zingarelli","year":"2003","journal-title":"J. Immunol."},{"key":"ref_559","doi-asserted-by":"crossref","first-page":"L303","DOI":"10.1152\/ajplung.90276.2008","article-title":"Peroxisome proliferator-activated receptor-\u03b3 in cystic fibrosis lung epithelium","volume":"295","author":"Perez","year":"2008","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_560","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1161\/01.RES.81.6.963","article-title":"Mevalonate-dependent inhibition of transendothelial migration and chemotaxis of human peripheral blood neutrophils by pravastatin","volume":"81","author":"Dunzendorfer","year":"1997","journal-title":"Circ. Res."},{"key":"ref_561","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/01.ATV.0000022694.16328.CC","article-title":"Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients","volume":"22","author":"Maca","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_562","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/phrs.2001.0922","article-title":"Modulation of inflammatory mediators and PPAR\u03b3 and NF\u03baB expression by pravastatin in response to lipoproteins in human monocytes in vitro","volume":"45","author":"Zelvyte","year":"2002","journal-title":"Pharmacol. Res."},{"key":"ref_563","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/path.1963","article-title":"Anti-inflammatory effect of augmented nitric oxide production in chronic lung infection","volume":"209","author":"Hopkins","year":"2006","journal-title":"J. Pathol."},{"key":"ref_564","first-page":"CD002201","article-title":"Omega-3 fatty acid supplementation for cystic fibrosis","volume":"2020","author":"Watson","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_565","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.intimp.2009.01.005","article-title":"Anti-inflammatory and anti-asthmatic effects of resveratrol, a polyphenolic stilbene, in a mouse model of allergic asthma","volume":"9","author":"Lee","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"ref_566","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1089\/ars.2009.3064","article-title":"Antioxidant and anti-inflammatory effects of resveratrol in airway disease","volume":"13","author":"Wood","year":"2010","journal-title":"Antioxidants Redox Signal."},{"key":"ref_567","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S1569-1993(11)60087-8","article-title":"68* Feasibility study of OSCN\u2212 and lactoferrin (Meveol\u00ae) nebulization for cystic fibrosis patients","volume":"10","author":"Georgi","year":"2011","journal-title":"J. Cyst. Fibros."},{"key":"ref_568","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1165\/rcmb.2014-0208OC","article-title":"Antiinflammatory and antimicrobial effects of thiocyanate in a cystic fibrosis mouse model","volume":"53","author":"Chandler","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_569","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1207\/s15327914nc5502_13","article-title":"Induction of phase II enzyme activity by various selenium compounds","volume":"55","author":"Xiao","year":"2006","journal-title":"Nutr. Cancer"},{"key":"ref_570","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2174\/138920007782798180","article-title":"Interactions of Polyphenolic Compounds with Drug Disposition and Metabolism","volume":"8","author":"Galli","year":"2007","journal-title":"Curr. Drug Metab."},{"key":"ref_571","doi-asserted-by":"crossref","first-page":"18825","DOI":"10.1073\/pnas.0904709106","article-title":"Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770","volume":"106","author":"Hadida","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/23\/9317\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:41:55Z","timestamp":1760179315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/23\/9317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,7]]},"references-count":571,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["ijms21239317"],"URL":"https:\/\/doi.org\/10.3390\/ijms21239317","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,7]]}}}